DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
up	IGKV3D-20; IGKV1-12; IGLC7; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV2D-40; IGKV2D-28; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-51; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGHG3; IGHG4; C1QA; C1QB; C1QC; C9; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; CFI; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; IGLC2; IGLC3; C4BPB; IGHV1-2; IGLV3-21; IGHV1-18; TRDC; IGHV4-4; IGHV3-21; IGHV5-51; IGHV3-20; IGHD; IGHV1-24; IGHV1-69-2; IGHV3-49; IGHV4-61; IGHV4-31; TRBC2; IGLL5; IGHV2-26; IGHV3-15; TRBC1; IGHV1OR15-9; IGHV6-1; IGHV3-74; IGHV1-3; IGHV3-66; IGHV3-72; IGHA2; IGHV3-43; IGHV3-73;	GO:0006958~complement activation, classical pathway	85	161	52.7950310559006	0	0	0	0	0	0	0
up	TRAV19; IGKV3D-20; IGKV1-12; IGLC7; CD300LB; NCR3; TYROBP; LILRA1; NCR1; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV1D-12; IGKV2D-40; IGKV2D-28; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-51; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; TRBC1; IGLV7-43; CD3D; IGKV1-16; IGKV1D-39; IGKV3-11; TRBV7-9; TRAV29DV5; CD1A; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; CD3G; IGLC2; IGLC3; CD8B; IGHV1-2; KLRC1; CD1B; CD1C; CD40LG; FCGR2B; ICAM3; CXADR; IGLV3-21; TREML2; LAIR2; CLEC4G; LILRB2; LILRB1; CD300LF; KIR2DL4; TREM2; CD300A; SIGLEC7; BTNL8; VTCN1;	GO:0050776~regulation of immune response	82	216	37.962962962963	0	0	0	0	0	0	0
down	ISLR; NCAN; TGFB1I1; NUAK1; MPDZ; BMP10; ITGBL1; FN1; APP; LAMB1; LAMC1; COL6A1; COL6A2; COL6A3; CCL2; CDH2; COL5A1; TNXB; ANOS1; LAMA2; LAMA1; COL8A1; L1CAM; THBS2; COL15A1; CXCL12; CCL11; MFAP4; CDH11; CDH15; SRPX; COL7A1; COL16A1; DPT; MFGE8; SPOCK1; FAP; MYBPH; LAMC2; COL4A6; NID2; OPCML; HEPACAM; LAMA4; DDR2; CDON; SVEP1; CERCAM; CGREF1; FEZ1; COL12A1; ADAM2; MXRA8; CNTNAP4; HAPLN2; NTM; ITGA11; CNTN6; LOXL2; EMILIN1; NINJ2; PCDHA3; PCDHA7; PCDHGA2; PCDHB2; PCDHB5; SPON2; PCDHB10; PCDHGC5; PCDHGB4; PCDHGC3; PCDH18; PCDHGA11; PCDHGA12;	GO:0007155~cell adhesion	74	454	16.2995594713656	0	0	0	0	0	0	0
down	TNFRSF11B; NCAN; MATN3; COL1A1; COL3A1; COL4A1; FGA; FGG; FN1; APP; SERPINE1; COL5A2; DCN; LAMB1; COL1A2; COL4A2; FGF2; LAMC1; COL11A1; COL6A1; COL6A2; COL6A3; ELN; PDGFRA; COL5A1; BGN; FBLN1; LAMA2; LAMA1; ITGA3; COL8A1; COL4A5; FBN1; COMP; LUM; ITGA8; MFAP2; LAMB2; ADAMTS20; FBLN2; COL7A1; COL14A1; COL16A1; LOXL1; FOXF1; FOXF2; DMP1; ITGA7; LAMC2; COL4A6; NID2; LAMA4; DDR2; CCDC80; ABI3BP; PXDN; FBLN5; ITGA11; MMP2; COL15A1; MMP23B; COL22A1; MMP16; MMP17; RECK;	GO:0030198~extracellular matrix organization	65	230	28.2608695652174	0	0	0	0	0	0	0
down	GRIA1; KCNA1; GRM1; GRIK4; FGF14; KCND2; GABRA2; GABRA1; GABRA6;	GO:0060078~regulation of postsynaptic membrane potential	9	35	25.7142857142857	0.00011875934819261	0.00561030607546051	0.455917137711429	0.465655404263223	0.388343068589834	0.455917137711429	0.0496593166714391
down	HOXC11; GREM1; GLI2; EN1; DLX2; SP8; HOXC10; HOXC9;	GO:0009954~proximal/distal pattern formation	8	27	29.6296296296296	0.00012413367656449	0.00573948644981644	0.476425050654541	0.486728145809394	0.400082839567375	0.476425050654541	0.0508027496734165
down	WNT7A; MGP; FGF4; COL11A1; BMP1; ROR2; OTOR;	GO:0001502~cartilage condensation	7	20	35	0.00014096834638754	0.00628110097938158	0.54061360839625	0.552736886185579	0.429074735388997	0.540472640049862	0.0555968209906967
down	SNAI2; GREM1; GLI2; GDF5; ADAMTS12; EFEMP1; ADAMTS7;	GO:0032331~negative regulation of chondrocyte differentiation	7	20	35	0.00014096834638754	0.00628110097938158	0.54061360839625	0.552736886185579	0.429074735388997	0.540472640049862	0.0555968209906967
down	WNT7A; NUPR1; GREM1; NGF; CRYAB; IGF1; HPN; FGF4; PDGFRB; GLI2; PIM1; MIF; NQO1; AZU1; POU3F3; EDNRB; MSX1; CDKN1A; GDNF; PTGFR; COMP; HMGA2; SOX8; ADAMTS20; ACTC1; BNIP3; ANGPT1; RGN; TWIST1; ASIC2; SCX; AMIGO2; PDPN; STK40; OSR1; TWIST2; BIRC7; RNF157; FAIM2; ARNT2; FMN2; SIX4; AXL;	GO:0043066~negative regulation of apoptotic process	43	489	8.79345603271984	0.00015430415955308	0.00672251788452949	0.591293539407429	0.605026609607654	0.450330236641503	0.591293539407429	0.0595039985282551
down	WNT7A; GLI2; FGFR1; HMGA2; SCX; OSR2; OSR1; SIX2; CYTL1;	GO:0002062~chondrocyte differentiation	9	37	24.3243243243243	0.00017030629374847	0.0072583801933455	0.652443411350423	0.667770977787786	0.475665478439502	0.652273105056674	0.0642471543789095
down	ITGA3; COL8A1; NPY2R; FOXF1; DMP1; CCDC80; ABI3BP; EMILIN1; FBLN2;	GO:0010811~positive regulation of cell-substrate adhesion	9	37	24.3243243243243	0.00017030629374847	0.0072583801933455	0.652443411350423	0.667770977787786	0.475665478439502	0.652273105056674	0.0642471543789095
down	FGF10; VEGFD; SCG2; AZU1; VEGFC; CXCL12;	GO:0050930~induction of positive chemotaxis	6	14	42.8571428571429	0.00017701938800507	0.00738396830178608	0.677630217283419	0.694093020367891	0.48609523946193	0.677630217283419	0.0653587906360643
down	FLRT2; LEFTY1; TH; COL5A1; TGFB2; FAT4; ALPK2; DLC1; MESP1;	GO:0003007~heart morphogenesis	9	38	23.6842105263158	0.00020235189272088	0.00826481011831872	0.774198341550113	0.793421771358597	0.520853771863562	0.774198341550113	0.0731555136875869
down	TERT; FGA; FGG; SERPINE1; SCG2; IL11; ANGPT1; FGF21;	GO:2000352~negative regulation of endothelial cell apoptotic process	8	30	26.6666666666667	0.00022895162898328	0.00906787209336837	0.875282077603107	0.897719337243469	0.552231329107689	0.875282077603107	0.0802637727360932
down	FLRT2; CTNNA2; NKX6-1; UNC5D; SCRT1; CAMK2A;	GO:2001222~regulation of neuron migration	6	15	40	0.00023848122464387	0.00911921215929609	0.911475240588878	0.935084881828621	0.562424804088144	0.911475240588878	0.0807182065152035
down	MEGF8; LAMB1; LAMC1; LAMB2; TMEFF1; LAMC2; LAMA2; LAMA1; BARX1;	GO:0009888~tissue development	9	39	23.0769230769231	0.00023925200083174	0.00911921215929609	0.914181895178104	0.938107095261279	0.563217548615829	0.914181895178104	0.0807182065152035
down	FGF4; FGF7; MSX1; HAND2;	GO:0010463~mesenchymal cell proliferation	4	4	100	0.00023955084223603	0.00911921215929609	0.915084217341657	0.939278852407497	0.563615773086512	0.914844666499421	0.0807182065152035
down	COL11A1; COL5A1; COMP; SCX;	GO:0035989~tendon development	4	4	100	0.00023955084223603	0.00911921215929609	0.915084217341657	0.939278852407497	0.563615773086512	0.914844666499421	0.0807182065152035
down	EFEMP2; TNXB; MFAP4; FBLN5; EMILIN1;	GO:0048251~elastic fiber assembly	5	9	55.5555555555556	0.00025143447176145	0.00947956311323728	0.959976813185247	0.985874563776677	0.576287809277262	0.959976813185247	0.0839078332296697
down	PITX3; AGT; PENK; DCN; COL4A2; PDGFRB; NQO1; TIMP2; ALOX12; EDNRB; TACR3; ADRA1A; NPY2R; FOXG1; KRT83; SLC6A3; LRP1; RGN; AMFR; LOXL2;	GO:0007568~aging	20	166	12.0481927710843	0.00026709397904123	0.00997405230305404	1	1	0.592955790598395	0.999987587534406	0.0882847771855658
up	UGT1A9; UGT1A1; UGT1A3; UGT1A7; UGT1A8; UGT1A6; UGT1A10;	GO:0052696~flavonoid glucuronidation	7	7	100	0.0003334416906543	0.0505561115734903	1	1	1	1	0.436969932329249
down	PDGFRB; LAMC1; FGFR1; CDH2; COL5A1; L1CAM; BDKRB1; ADAMTS12; TGFB2; FSCN1; SYDE1; PALLD; CTHRC1; SPATA13; SIX2; GPC6; EMILIN1; GPC4; ITGBL1; AXL; LAMB2; CD248; LAMB1; SDC3;	GO:0016477~cell migration	24	225	10.6666666666667	0.00036502808169203	0.0132525472992079	1	1	0.682629915069297	0.999987587534406	0.117304195917791
down	FXYD1; TH; CHRM2; TPM1; DES; DMPK; TBX2; HSPB7;	GO:0008016~regulation of heart contraction	8	33	24.2424242424242	0.00039716248600996	0.014286918418762	1	1	0.703736754383229	0.999987587534406	0.126459875178571
down	SOX11; HAND2; SOX4; PHOX2B;	GO:0003357~noradrenergic neuron differentiation	4	5	80	0.00041591577070465	0.0146919435759726	1	1	0.715416916164099	0.999987587534406	0.130044933154249
down	GABBR2; ADRA1D; ADRA1A; ADRA1B;	GO:0150099~neuron-glial cell signaling	4	5	80	0.00041591577070465	0.0146919435759726	1	1	0.715416916164099	0.999987587534406	0.130044933154249
down	NLGN1; SLITRK1; LRRC4C; LRRC4B; CDH9; GPC6; GPC4;	GO:0099560~synaptic membrane adhesion	7	25	28	0.00043937432946361	0.015382024516311	1	1	0.729216168979966	0.999987587534406	0.136153146767599
down	CDH2; CDH11; CDH13; CDH15; CDH18; CADM3; CDH9; CDH10; NUMBL;	GO:0034332~adherens junction organization	9	43	20.9302325581395	0.00044711081529547	0.015514349617465	1	1	0.733708847899867	0.999987587534406	0.137324415146436
up	UGT1A9; UGT2B17; UGT2B7; UGT1A6; UGT1A1; UGT1A4; UGT1A3; UGT1A7; UGT1A10;	GO:0052695~cellular glucuronidation	9	14	64.2857142857143	0.00045745077736536	0.06620560341506	1	1	1	1	0.572232656818204
down	OPRM1; OPRK1; SCN10A; PENK; PDYN;	GO:0007600~sensory perception	5	11	45.4545454545455	0.00050903247380873	0.0173407859196847	1	1	0.766602905555955	0.999987587534406	0.153491015950778
down	FGF10; SOX11; WNT3; SOX4; SEMA3C;	GO:0060174~limb bud formation	5	11	45.4545454545455	0.00050903247380873	0.0173407859196847	1	1	0.766602905555955	0.999987587534406	0.153491015950778
down	EDNRB; GDNF; GBX2; SOX8; ISL1; SEMA3C; SEMA4A; SEMA3E; SEMA6D;	GO:0001755~neural crest cell migration	9	44	20.4545454545455	0.00051743737633336	0.0173407859196847	1	1	0.770710675041655	0.999987587534406	0.153491015950778
down	COL11A1; PDGFRA; HOXB8; PCGF2; SOX11; SIX1; MEGF8; OSR2; HOXC9;	GO:0048704~embryonic skeletal system morphogenesis	9	44	20.4545454545455	0.00051743737633336	0.0173407859196847	1	1	0.770710675041655	0.999987587534406	0.153491015950778
down	GREM1; AGT; GDNF; SOX8; SIX1; SIX4;	GO:0090190~positive regulation of branching involved in ureteric bud morphogenesis	6	18	33.3333333333333	0.00052721068341909	0.017518585505816	1	1	0.775526915309495	0.999987587534406	0.155064799240493
down	TERT; SLIT3; CILP; STC2; APOE; IGF1; APP; ROS1; FGF2; MIF; SOX11; CDKN1A; OPRD1; HAND2; TGFB2; RBMS3; SAMD7; CREB3L1; ZNF503; ATOH8; APLN; EMILIN1;	GO:0010629~negative regulation of gene expression	22	204	10.7843137254902	0.00054815372554351	0.0179109229821342	1	1	0.784407981252763	0.999987587534406	0.158537552904286
down	CDH2; CDH18; CDH11; CDH9; CDH15; CDH13; CDH10;	GO:0044331~cell-cell adhesion mediated by cadherin	7	27	25.9259259259259	0.00064953078895979	0.0207057741748891	1	1	0.825884250549034	0.999987587534406	0.183276025023951
down	FGF18; COL1A1; MMP2; MN1;	GO:0001957~intramembranous ossification	4	6	66.6666666666667	0.00066867427204231	0.0209749745654233	1	1	0.833806552133617	0.999987587534406	0.18565883752327
down	SYT1; GDNF; CXCL12; NPY2R;	GO:0033603~positive regulation of dopamine secretion	4	6	66.6666666666667	0.00066867427204231	0.0209749745654233	1	1	0.833806552133617	0.999987587534406	0.18565883752327
down	MYF6; ROR2; FOXF1; RIPPLY2; FOXC2; SEMA3C; HES7; TBX18; MESP1;	GO:0001756~somitogenesis	9	46	19.5652173913043	0.00068534939612352	0.0211154712940429	1	1	0.840493052150727	0.999987587534406	0.186902436614653
down	FGF10; VEGFD; FGF2; SCG2; MIF; FGF7; VEGFC; ANGPT1; COLEC10;	GO:0050918~positive chemotaxis	9	46	19.5652173913043	0.00068534939612352	0.0211154712940429	1	1	0.840493052150727	0.999987587534406	0.186902436614653
down	TRABD2B; WNT7A; TGFB1I1; GPC4; WNT2; WNT3; HHEX; HIC1; RSPO4; RSPO1; CPZ; NOTUM; AMER2; FERMT2; DACT3; ADGRA2; RSPO3; PORCN; DKK3; DKK2; AMFR;	GO:0016055~Wnt signaling pathway	21	194	10.8247422680412	0.00069214441844034	0.0211154712940429	1	1	0.84326010746645	0.999987587534406	0.186902436614653
down	ASIC2; LRRTM1; NLGN1; NLGN2; SHANK1;	GO:0035418~protein localization to synapse	5	12	41.6666666666667	0.00069469415887057	0.0211154712940429	1	1	0.844311897079954	0.999987587534406	0.186902436614653
down	WNT7A; FGF4; MSX1; WNT3; TWIST1; OSR2; OSR1;	GO:0035116~embryonic hindlimb morphogenesis	7	28	25	0.00078088006705689	0.0227884145799124	1	1	0.874046437026636	0.999987587534406	0.201710402399216
down	TRABD2B; LRP1; HIC1; NFATC4; SFRP4; NOTUM; APCDD1L; DACT3; BARX1;	GO:0030178~negative regulation of Wnt signaling pathway	9	47	19.1489361702128	0.00078460493962972	0.0227884145799124	1	1	0.87512713376723	0.999987587534406	0.201710402399216
down	GREM1; FSTL3; NBL1; HTRA3; RBPMS2; BMPER; HTRA1; CHRDL1; CHRD;	GO:0030514~negative regulation of BMP signaling pathway	9	47	19.1489361702128	0.00078460493962972	0.0227884145799124	1	1	0.87512713376723	0.999987587534406	0.201710402399216
down	VEGFD; IGF2; FGF1; FGF4; FGF2; FGF5; FGF7; VEGFC; TGFB2;	GO:0051781~positive regulation of cell division	9	47	19.1489361702128	0.00078460493962972	0.0227884145799124	1	1	0.87512713376723	0.999987587534406	0.201710402399216
down	BMP10; AGT; IGF1; ADRA1A; MTPN; HAND2;	GO:0010613~positive regulation of cardiac muscle hypertrophy	6	20	30	0.00083534581406064	0.0236952390335353	1	1	0.889643291974581	0.999987587534406	0.209737109338582
down	FGFR1; MSX1; SIX1; OSR2; OSR1; SIX2;	GO:0042474~middle ear morphogenesis	6	20	30	0.00083534581406064	0.0236952390335353	1	1	0.889643291974581	0.999987587534406	0.209737109338582
down	SCG2; CCL11; CCL7; CCL13; CCL8; CCL2;	GO:0048245~eosinophil chemotaxis	6	20	30	0.00083534581406064	0.0236952390335353	1	1	0.889643291974581	0.999987587534406	0.209737109338582
down	HSPB6; TPM1; TNNI2; KCNA1; TNNC2;	GO:0006937~regulation of muscle contraction	5	13	38.4615384615385	0.00092666572486621	0.0255645194631115	1	1	0.914746754149311	0.999987587534406	0.226282942587516
down	SLIT2; SERPINE1; IGFBP3; LRP1; SEMA6D;	GO:0014912~negative regulation of smooth muscle cell migration	5	13	38.4615384615385	0.00092666572486621	0.0255645194631115	1	1	0.914746754149311	0.999987587534406	0.226282942587516
down	IGF1; AR; IGFBP3; IGFBP4; GHRHR;	GO:0043568~positive regulation of insulin-like growth factor receptor signaling pathway	5	13	38.4615384615385	0.00092666572486621	0.0255645194631115	1	1	0.914746754149311	0.999987587534406	0.226282942587516
down	FGF10; HOXC11; FBN1; GDNF; ITGA8; OSR2; FOXC2;	GO:0001656~metanephros development	7	29	24.1379310344828	0.00093234539230424	0.0255645194631115	1	1	0.916490840587594	0.999987587534406	0.226282942587516
down	GREM1; GDNF; SIX2; SALL1;	GO:0003337~mesenchymal to epithelial transition involved in metanephros morphogenesis	4	7	57.1428571428571	0.00101366680746451	0.0273456393768784	1	1	0.937869130776246	0.999987587534406	0.2420484278637
down	SEMA3E; APP; L1CAM; DRP2; LRRTM1; CBLN2; NLGN2; PCDHGC3; PCDHGC5;	GO:0050808~synapse organization	9	49	18.3673469387755	0.00101822579674171	0.0273456393768784	1	1	0.939022743688803	0.999987587534406	0.2420484278637
down	FSTL3; PDGFRB; PDGFRA; NR0B1; SALL1; DKK3;	GO:0030325~adrenal gland development	6	21	28.5714285714286	0.00103373937616791	0.0275734156051318	1	1	0.942943977261075	0.999987587534406	0.244064576661451
down	MATN2; KCNK2; LGALS1; GIP; BNIP3; DPYSL3; MORN4;	GO:0048678~response to axon injury	7	30	23.3333333333333	0.0011060093256956	0.0291051178929695	1	1	0.952610691878722	0.999987587534406	0.257622355494731
down	DCN; ELN; MYF6; NR2F2; SIX1; BVES; MYOZ1; SIX4; POPDC3;	GO:0007519~skeletal muscle tissue development	9	50	18	0.00115452920890791	0.0301793935208527	1	1	0.959080131069558	0.999987587534406	0.267131247323433
down	IGF2; CDH2; MTPN; BVES; POPDC3;	GO:0051146~striated muscle cell differentiation	5	14	35.7142857142857	0.00121162697137267	0.03125519312337	1	1	0.966628750177726	0.999987587534406	0.276653628530065
down	SCG2; CDH13; FAP; ADGRA2; STARD13; LOXL2; TGFB1I1;	GO:0043542~endothelial cell migration	7	31	22.5806451612903	0.00130405461213756	0.033017188696958	1	1	0.978769288854998	0.999987587534406	0.292249835757546
down	COL1A1; COL3A1; COL4A1; COL5A2; COL1A2; MMP2; COL6A1; PDGFRA; COL16A1;	GO:0071230~cellular response to amino acid stimulus	9	51	17.6470588235294	0.00130519363632453	0.033017188696958	1	1	0.978895227243398	0.999987587534406	0.292249835757546
down	HTR1B; EN1; APLN; MMP17;	GO:0042756~drinking behavior	4	8	50	0.00146689200194716	0.0359480221227176	1	1	0.996044320066134	0.999987587534406	0.318191947158142
down	FGFR1; HMGA2; ISL1; WWTR1;	GO:0048762~mesenchymal cell differentiation	4	8	50	0.00146689200194716	0.0359480221227176	1	1	0.996044320066134	0.999987587534406	0.318191947158142
down	PDGFRB; SIX1; OSR1; SIX4;	GO:0072075~metanephric mesenchyme development	4	8	50	0.00146689200194716	0.0359480221227176	1	1	0.996044320066134	0.999987587534406	0.318191947158142
down	MELTF; FSCN1; DDR2; PDPN;	GO:0090091~positive regulation of extracellular matrix disassembly	4	8	50	0.00146689200194716	0.0359480221227176	1	1	0.996044320066134	0.999987587534406	0.318191947158142
down	PDGFRA; MMP16; DLX2; SIX1; TWIST1; SIX2; SIX4;	GO:0048701~embryonic cranial skeleton morphogenesis	7	32	21.875	0.00152875957064802	0.0362881962780355	1	1	0.999987587534405	0.999987587534406	0.321202980045681
down	CCL2; ROR2; NLGN1; NLGN2; SHANK3; SHANK1;	GO:0051968~positive regulation of synaptic transmission, glutamatergic	6	23	26.0869565217391	0.00153697209101333	0.0362881962780355	1	1	0.999987587534405	0.999987587534406	0.321202980045681
down	FXYD1; ATP10A; ATP6V1B1; GJC1; GRIA1; CLCNKB; ASIC1; GRIK2; SLC12A1; GRIK4; ASIC2; ATP2B3; ANO4; SLC24A5; NALCN; CHRNA1; GABRA2; GABRA1; GABRA6; GLRB; GABRR3;	GO:0034220~ion transmembrane transport	21	208	10.0961538461538	0.00153849129152439	0.0362881962780355	1	1	0.999987587534405	0.999987587534406	0.321202980045681
down	SOX11; GDNF; HAND2; SOX4; PHOX2B;	GO:0048485~sympathetic nervous system development	5	15	33.3333333333333	0.00155649616579745	0.0362881962780355	1	1	0.999987587534405	0.999987587534406	0.321202980045681
down	OBSL1; PDGFRB; PDGFRA; ACTC1; FHOD3;	GO:0055003~cardiac myofibril assembly	5	15	33.3333333333333	0.00155649616579745	0.0362881962780355	1	1	0.999987587534405	0.999987587534406	0.321202980045681
down	TCF21; FGF2; HOXD11; GDNF; SIX1; FAT4; ADAMTS16; SALL1;	GO:0001658~branching involved in ureteric bud morphogenesis	8	42	19.047619047619	0.00156406660826014	0.0362881962780355	1	1	0.999987587534406	0.999987587534406	0.321202980045681
down	TGFB1I1; COL1A1; ISL1; TGFB2; TWIST1; PDPN; WWTR1; LOXL2;	GO:0010718~positive regulation of epithelial to mesenchymal transition	8	42	19.047619047619	0.00156406660826014	0.0362881962780355	1	1	0.999987587534406	0.999987587534406	0.321202980045681
down	FBN1; MFAP2; EFEMP1;	GO:0048050~post-embryonic eye morphogenesis	3	3	100	0.00160309327040387	0.0363336919841246	1	1	0.999987587534406	0.999987587534406	0.321605682794066
down	SERPINE2; ASIC2; PIEZO2;	GO:0050974~detection of mechanical stimulus involved in sensory perception	3	3	100	0.00160309327040387	0.0363336919841246	1	1	0.999987587534406	0.999987587534406	0.321605682794066
down	TCF21; PDGFRB; PDGFRA;	GO:0072277~metanephric glomerular capillary formation	3	3	100	0.00160309327040387	0.0363336919841246	1	1	0.999987587534406	0.999987587534406	0.321605682794066
down	FGF1; FGF4; FGF2;	GO:2000544~regulation of endothelial cell chemotaxis to fibroblast growth factor	3	3	100	0.00160309327040387	0.0363336919841246	1	1	0.999987587534406	0.999987587534406	0.321605682794066
up	CXCL11; CXCL10; CXCR1; CCR2; CXCR3; CCR5; CCR6; CCR8; ACKR1; CCL26; CCL23; CXCL9; CCL24; CCL14; TFF2; XCL2; CXCL13; XCL1; CCL18; CCL19;	GO:0070098~chemokine-mediated signaling pathway	20	70	28.5714285714286	0.00165216564925252	0.228717192487828	1	1	1	1	1
down	LAMB1; COL1A2; INHBA; TGFB2; TWIST1; OSR2; OSR1;	GO:0042476~odontogenesis	7	33	21.2121212121212	0.00178249290754762	0.039938026802824	1	1	0.999987587534406	0.999987587534406	0.353509254853099
down	TERT; AGT; IGF1; MMP2; FGF2; HTR1B; ADAMTS1;	GO:1904707~positive regulation of vascular smooth muscle cell proliferation	7	33	21.2121212121212	0.00178249290754762	0.039938026802824	1	1	0.999987587534406	0.999987587534406	0.353509254853099
down	MEIS2; FGF10; WFS1; ISL1; NKX6-1; FOXF1;	GO:0031016~pancreas development	6	24	25	0.00184937658054962	0.0409683930640399	1	1	0.999987587534406	0.999987587534406	0.362629485329845
down	MATN2; AZU1; TGFB2; NDN;	GO:0008347~glial cell migration	4	9	44.4444444444444	0.00204426186160811	0.0440414876888209	1	1	0.999987587534406	0.999987587534406	0.389830813934857
down	COL1A1; COL5A1; SERPINH1; P3H3;	GO:0032964~collagen biosynthetic process	4	9	44.4444444444444	0.00204426186160811	0.0440414876888209	1	1	0.999987587534406	0.999987587534406	0.389830813934857
down	FN1; CXCL12; COL16A1; FERMT2;	GO:0033622~integrin activation	4	9	44.4444444444444	0.00204426186160811	0.0440414876888209	1	1	0.999987587534406	0.999987587534406	0.389830813934857
down	FBN1; MFAP2; FOXL2; EFEMP1;	GO:0048048~embryonic eye morphogenesis	4	9	44.4444444444444	0.00204426186160811	0.0440414876888209	1	1	0.999987587534406	0.999987587534406	0.389830813934857
down	SCX; TCF21; TWIST2; HAND2; TWIST1; COLEC10; HMGB4;	GO:0032502~developmental process	7	34	20.5882352941176	0.00206770799428879	0.0440624078565563	1	1	0.999987587534406	0.999987587534406	0.390015987652728
down	ADAMTS2; COL3A1; COL5A2; COL5A1; ITGA3; COMP; COL1A1;	GO:0043588~skin development	7	34	20.5882352941176	0.00206770799428879	0.0440624078565563	1	1	0.999987587534406	0.999987587534406	0.390015987652728
down	VIM; PDGFRB; SCX; CREB3L1; LARP6; SUCO;	GO:0032967~positive regulation of collagen biosynthetic process	6	25	24	0.00220756243129849	0.0465368402855989	1	1	0.999987587534406	0.999987587534406	0.411918290650666
down	FABP7; WNT2; SPOCK1; FAT4; NAV3; MESP1; CHAC1; PRDM6;	GO:0022008~neurogenesis	8	45	17.7777777777778	0.00229469727870557	0.0476058625915584	1	1	0.999987587534406	0.999987587534406	0.421380682988346
down	SERPINE2; GIP; SNAP25; NFATC4; LRRTM1; NLGN1; SHANK3; SHANK1;	GO:0060291~long-term synaptic potentiation	8	45	17.7777777777778	0.00229469727870557	0.0476058625915584	1	1	0.999987587534406	0.999987587534406	0.421380682988346
down	PITX3; HTR1B; TACR3; SLC6A1; OPRM1; RGS4; SLC6A3;	GO:0042220~response to cocaine	7	35	20	0.0023869366553072	0.0492588348708397	1	1	0.999987587534406	0.999987587534406	0.4360118765029
down	FGF10; FGF4; GLI2; PDGFRA; MSX1; HAND2; DLX2; LHX8; SCN10A;	GO:0042475~odontogenesis of dentin-containing tooth	9	57	15.7894736842105	0.00257410249505297	0.0518058432415005	1	1	0.999987587534406	0.999987587534406	0.458556581469476
down	PDGFRB; TGFB2; ROR1; SIX1; BMPER; PHOX2B; C1QTNF5; CYTL1;	GO:0048839~inner ear development	8	46	17.3913043478261	0.0025900221378522	0.0518058432415005	1	1	0.999987587534406	0.999987587534406	0.458556581469476
down	PLPP3; APP; ITGA3; FOXL1; RSPO3; DACT3;	GO:0030111~regulation of Wnt signaling pathway	6	26	23.0769230769231	0.00261560583941745	0.0518058432415005	1	1	0.999987587534406	0.999987587534406	0.458556581469476
down	WNT7A; RGS4; NLGN1; NLGN2; SHANK3; SHANK1;	GO:2000463~positive regulation of excitatory postsynaptic potential	6	26	23.0769230769231	0.00261560583941745	0.0518058432415005	1	1	0.999987587534406	0.999987587534406	0.458556581469476
down	ADRA1A; ADRA1D; ADRA1B;	GO:0001994~norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure	3	4	75	0.00271227694316845	0.0518058432415005	1	1	0.999987587534406	0.999987587534406	0.458556581469476
down	WNT7A; FZD7; IGF1;	GO:0014834~skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration	3	4	75	0.00271227694316845	0.0518058432415005	1	1	0.999987587534406	0.999987587534406	0.458556581469476
down	PHGDH; SOX11; SOX4;	GO:0021782~glial cell development	3	4	75	0.00271227694316845	0.0518058432415005	1	1	0.999987587534406	0.999987587534406	0.458556581469476
down	FGF10; FGFR1; FGF7;	GO:0060665~regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling	3	4	75	0.00271227694316845	0.0518058432415005	1	1	0.999987587534406	0.999987587534406	0.458556581469476
down	GDNF; SIX1; SIX4;	GO:0072107~positive regulation of ureteric bud formation	3	4	75	0.00271227694316845	0.0518058432415005	1	1	0.999987587534406	0.999987587534406	0.458556581469476
down	APOE; NLGN1; SHANK3;	GO:0097113~AMPA glutamate receptor clustering	3	4	75	0.00271227694316845	0.0518058432415005	1	1	0.999987587534406	0.999987587534406	0.458556581469476
down	APOE; NLGN1; SHANK3;	GO:0097114~NMDA glutamate receptor clustering	3	4	75	0.00271227694316845	0.0518058432415005	1	1	0.999987587534406	0.999987587534406	0.458556581469476
down	FGF18; FGF2; FGFR1;	GO:2000546~positive regulation of endothelial cell chemotaxis to fibroblast growth factor	3	4	75	0.00271227694316845	0.0518058432415005	1	1	0.999987587534406	0.999987587534406	0.458556581469476
down	TERT; WNT3; HHEX; RSPO4; RSPO1; RSPO3; SALL1;	GO:0030177~positive regulation of Wnt signaling pathway	7	36	19.4444444444444	0.00274278251419247	0.0518058432415005	1	1	0.999987587534406	0.999987587534406	0.458556581469476
down	FLRT2; SLIT3; SLIT2; SEMA3C; SEMA3E; SEMA6D; SEMA4A;	GO:0050919~negative chemotaxis	7	36	19.4444444444444	0.00274278251419247	0.0518058432415005	1	1	0.999987587534406	0.999987587534406	0.458556581469476
down	ITGA3; SFRP4; FSTL3; FSTL1;	GO:0030510~regulation of BMP signaling pathway	4	10	40	0.00276139281751431	0.0518058432415005	1	1	0.999987587534406	0.999987587534406	0.458556581469476
down	COMP; MMP16; HMGA2; DDR2;	GO:0035988~chondrocyte proliferation	4	10	40	0.00276139281751431	0.0518058432415005	1	1	0.999987587534406	0.999987587534406	0.458556581469476
down	OPRM1; ADCY8; OPRD1; OPRK1;	GO:0038003~opioid receptor signaling pathway	4	10	40	0.00276139281751431	0.0518058432415005	1	1	0.999987587534406	0.999987587534406	0.458556581469476
down	GPR37; TH; TGFB2; SLC6A3;	GO:0042416~dopamine biosynthetic process	4	10	40	0.00276139281751431	0.0518058432415005	1	1	0.999987587534406	0.999987587534406	0.458556581469476
down	IGF1; FOXL1; XYLT1; GAL3ST3; CHST8;	GO:0030166~proteoglycan biosynthetic process	5	18	27.7777777777778	0.00302217672425087	0.0548609024804984	1	1	0.999987587534406	0.999987587534406	0.485598270845925
down	NPY2R; MYOCD; ADRA1B; ADRA1D; ADRA1A;	GO:0045987~positive regulation of smooth muscle contraction	5	18	27.7777777777778	0.00302217672425087	0.0548609024804984	1	1	0.999987587534406	0.999987587534406	0.485598270845925
down	UCHL1; COMP; FLNC; SGCB; WFIKKN2;	GO:0048747~muscle fiber development	5	18	27.7777777777778	0.00302217672425087	0.0548609024804984	1	1	0.999987587534406	0.999987587534406	0.485598270845925
down	SYT1; GRIK2; KISS1; CLSTN2; RIMS4;	GO:0050806~positive regulation of synaptic transmission	5	18	27.7777777777778	0.00302217672425087	0.0548609024804984	1	1	0.999987587534406	0.999987587534406	0.485598270845925
down	TPM1; CDKN1A; CNN1; MYOCD; APLN;	GO:1904706~negative regulation of vascular smooth muscle cell proliferation	5	18	27.7777777777778	0.00302217672425087	0.0548609024804984	1	1	0.999987587534406	0.999987587534406	0.485598270845925
down	HMX3; ARGFX; VGLL3; SOX12; FSTL3; CGA; APOE; INHBA; MYF6; HOXD11; CDKN1A; KLF17; ATOH7; ZBTB8B; ISL2; PKNOX2; DACH2; NEUROD4; KCNIP3; HIF3A; DLX2; FOXD3; BARX1; SCX; NHLH2; SP9; HMGB4; FOXC2; FOXL2; SP8; ANKRD1; DLX6; EN1; NR2F1; EN2; FOXL1; TWIST1; ZNF101; KLF15; FOXS1; TCF21; CDX1; FOXD1; HAND2; ZIC4; ETV5; SIM1; TWIST2; GLIS2; NPAS4; NR2F2; ZIC1; MLXIP;	GO:0006357~regulation of transcription by RNA polymerase II	53	747	7.095046854083	0.00307439520199659	0.0551029327900626	1	1	0.999987587534406	0.999987587534406	0.487740588862994
down	FGF10; GLI2; MSX1; NR0B1; ISL1; SALL1;	GO:0021983~pituitary gland development	6	27	22.2222222222222	0.00307766954374489	0.0551029327900626	1	1	0.999987587534406	0.999987587534406	0.487740588862994
down	SERPINE2; GLI2; KIF7; MEGF8; SALL3; GLIS2;	GO:0045879~negative regulation of smoothened signaling pathway	6	27	22.2222222222222	0.00307766954374489	0.0551029327900626	1	1	0.999987587534406	0.999987587534406	0.487740588862994
down	APP; GIP; HOXB8; GDNF; PBX3; OPRD1; CXCL12; EN1;	GO:0008344~adult locomotory behavior	8	48	16.6666666666667	0.00326915788913384	0.0572248575147045	1	1	0.999987587534406	0.999987587534406	0.506522689239808
down	ISL1; TGFB2; TBX2; ZFPM2; SEMA3C; PARVA;	GO:0003148~outflow tract septum morphogenesis	6	28	21.4285714285714	0.0035979849912029	0.0616056731463168	1	1	0.999987587534406	0.999987587534406	0.545299238647867
down	SNAI2; SLIT3; SLIT2; ELN; TWIST1; EMILIN1;	GO:0003180~aortic valve morphogenesis	6	28	21.4285714285714	0.0035979849912029	0.0616056731463168	1	1	0.999987587534406	0.999987587534406	0.545299238647867
down	SHANK3; ADRA1D; ADRB3; ADRA1B; ADRA1A; SHANK1;	GO:0007610~behavior	6	28	21.4285714285714	0.0035979849912029	0.0616056731463168	1	1	0.999987587534406	0.999987587534406	0.545299238647867
down	COL3A1; FOXF1; FAT4; MYOCD; MIXL1; CLMP;	GO:0048565~digestive tract development	6	28	21.4285714285714	0.0035979849912029	0.0616056731463168	1	1	0.999987587534406	0.999987587534406	0.545299238647867
down	AGT; RCVRN; OPRD1; RGS4; CACNA2D1; ANK2;	GO:0051924~regulation of calcium ion transport	6	28	21.4285714285714	0.0035979849912029	0.0616056731463168	1	1	0.999987587534406	0.999987587534406	0.545299238647867
down	INHBA; ITGA3; HMGA2; ITGA8;	GO:0048333~mesodermal cell differentiation	4	11	36.3636363636364	0.00363342900951968	0.0616425895213746	1	1	0.999987587534406	0.999987587534406	0.545626001917945
down	DLX2; OSR2; OSR1; DLX6; CDX1;	GO:0009790~embryo development	5	19	26.3157894736842	0.003678746735017	0.0616425895213746	1	1	0.999987587534406	0.999987587534406	0.545626001917945
down	FGF18; GDF5; PKDCC; GDF6; LOXL2;	GO:0032332~positive regulation of chondrocyte differentiation	5	19	26.3157894736842	0.003678746735017	0.0616425895213746	1	1	0.999987587534406	0.999987587534406	0.545626001917945
down	CHRNA1; UCHL1; COMP; KCNA1; HOXC10;	GO:0050905~neuromuscular process	5	19	26.3157894736842	0.003678746735017	0.0616425895213746	1	1	0.999987587534406	0.999987587534406	0.545626001917945
down	BMP10; ADRA1B; ANK2; HCN4; SCN10A;	GO:0055117~regulation of cardiac muscle contraction	5	19	26.3157894736842	0.003678746735017	0.0616425895213746	1	1	0.999987587534406	0.999987587534406	0.545626001917945
up	S100A8; S100A9; SAA1; EDN3; XCL1; NCKAP1L; CXADR; S100A12; CXCL9; XCL2; CXCR1; CCL14; CXCL10; CCL26; CCL18; CCL19; CXCL13; CCL23; CXCL11; CCL24;	GO:0030593~neutrophil chemotaxis	20	76	26.3157894736842	0.00367891457797709	0.450525539087656	1	1	1	1	1
down	FGF18; FGF2; FGFR1; ALOX12; MAP2K3; VEGFC; ANGPT1;	GO:0043536~positive regulation of blood vessel endothelial cell migration	7	39	17.9487179487179	0.00405698613995853	0.0674269398328493	1	1	0.999987587534406	0.999987587534406	0.596825861603405
down	CHRNA1; KCNA1; GRIK2; GPR88; KCND2; SCN10A;	GO:0019228~neuronal action potential	6	29	20.6896551724138	0.00418083428585214	0.0674269398328493	1	1	0.999987587534406	0.999987587534406	0.596825861603405
down	EDNRB; OPRM1; OPRD1; NPY2R; GRM1; TMEM100;	GO:0051930~regulation of sensory perception of pain	6	29	20.6896551724138	0.00418083428585214	0.0674269398328493	1	1	0.999987587534406	0.999987587534406	0.596825861603405
down	SOX11; SOX4; MESP1;	GO:0003211~cardiac ventricle formation	3	5	60	0.00419591260372743	0.0674269398328493	1	1	0.999987587534406	0.999987587534406	0.596825861603405
down	APOE; MIF; EDNRB;	GO:0032269~negative regulation of cellular protein metabolic process	3	5	60	0.00419591260372743	0.0674269398328493	1	1	0.999987587534406	0.999987587534406	0.596825861603405
down	GREM1; NBL1; GREM2;	GO:0048263~determination of dorsal identity	3	5	60	0.00419591260372743	0.0674269398328493	1	1	0.999987587534406	0.999987587534406	0.596825861603405
down	APP; SHANK1; SHANK3;	GO:0051124~synaptic growth at neuromuscular junction	3	5	60	0.00419591260372743	0.0674269398328493	1	1	0.999987587534406	0.999987587534406	0.596825861603405
down	FGF4; FGF2; GDF5;	GO:0060591~chondroblast differentiation	3	5	60	0.00419591260372743	0.0674269398328493	1	1	0.999987587534406	0.999987587534406	0.596825861603405
down	FGA; FGG; FBLN1;	GO:0072378~blood coagulation, fibrin clot formation	3	5	60	0.00419591260372743	0.0674269398328493	1	1	0.999987587534406	0.999987587534406	0.596825861603405
down	CDH2; NLGN1; NLGN2;	GO:2000809~positive regulation of synaptic vesicle clustering	3	5	60	0.00419591260372743	0.0674269398328493	1	1	0.999987587534406	0.999987587534406	0.596825861603405
up	UGT1A9; UGT1A1; UGT1A7; UGT1A10; UGT1A8;	GO:0051552~flavone metabolic process	5	6	83.3333333333333	0.00422505456169842	0.498243471275843	1	1	1	1	1
down	PPP1R1A; RGN; CRY2; ELFN2; PPP4R4; MYOZ1; PPP1R1B; BOD1L2;	GO:0032515~negative regulation of phosphoprotein phosphatase activity	8	51	15.6862745098039	0.00453762073985509	0.0724516261597677	1	1	0.999987587534406	0.999987587534406	0.641301597174143
down	HMX3; STC2; RECK; MMP2; LIF; FBLN1; PTGIS;	GO:0007566~embryo implantation	7	40	17.5	0.0045865194480017	0.0724516261597677	1	1	0.999987587534406	0.999987587534406	0.641301597174143
down	NCAN; DCN; BGN; DSEL;	GO:0030208~dermatan sulfate biosynthetic process	4	12	33.3333333333333	0.00467489452140302	0.0724516261597677	1	1	0.999987587534406	0.999987587534406	0.641301597174143
down	SOX8; TMEM119; CTHRC1; FBLN5;	GO:0033690~positive regulation of osteoblast proliferation	4	12	33.3333333333333	0.00467489452140302	0.0724516261597677	1	1	0.999987587534406	0.999987587534406	0.641301597174143
down	KERA; LUM; PRELP; FMOD;	GO:0042340~keratan sulfate catabolic process	4	12	33.3333333333333	0.00467489452140302	0.0724516261597677	1	1	0.999987587534406	0.999987587534406	0.641301597174143
down	MSX1; HIC1; ANKRD1; SPRED3;	GO:0043517~positive regulation of DNA damage response, signal transduction by p53 class mediator	4	12	33.3333333333333	0.00467489452140302	0.0724516261597677	1	1	0.999987587534406	0.999987587534406	0.641301597174143
down	EDNRB; GDNF; SOX8; PHOX2B;	GO:0048484~enteric nervous system development	4	12	33.3333333333333	0.00467489452140302	0.0724516261597677	1	1	0.999987587534406	0.999987587534406	0.641301597174143
down	FGG; SERPINE2; ALOX12; ADAMTS18;	GO:0090331~negative regulation of platelet aggregation	4	12	33.3333333333333	0.00467489452140302	0.0724516261597677	1	1	0.999987587534406	0.999987587534406	0.641301597174143
down	GABRA1; GABRA2; NPAS4; NLGN2;	GO:1904862~inhibitory synapse assembly	4	12	33.3333333333333	0.00467489452140302	0.0724516261597677	1	1	0.999987587534406	0.999987587534406	0.641301597174143
down	ATP6V1B1; RNF180; SLITRK1; ADAM2; SHANK3; SHANK1;	GO:0030534~adult behavior	6	30	20	0.00483053206459605	0.0739863915050043	1	1	0.999987587534406	0.999987587534406	0.654886488492074
down	MSX1; CDX1; RIPPLY2; SFRP4; OSR2; PAPPA2;	GO:0060349~bone morphogenesis	6	30	20	0.00483053206459605	0.0739863915050043	1	1	0.999987587534406	0.999987587534406	0.654886488492074
down	HMX3; EML1; PHGDH; UNC5C; COL4A1; SYT1; PTPRG; RGS4; ITGA8; FOXG1; DLX2; ZIC1; MAP1S; CTTNBP2; ARNT2; PCDH18; AMIGO2; SCTR; SCT; CDH2;	GO:0007420~brain development	20	217	9.21658986175115	0.00505150533940979	0.077069853835898	1	1	0.999987587534406	0.999987587534406	0.682179586279387
down	SCT; HTR5A; EPHA5; DLX2; KCNA1; CDK5R2; NCOA1; DCLK2; FEZ1;	GO:0021766~hippocampus development	9	64	14.0625	0.00511629501308086	0.0777557858383336	1	1	0.999987587534406	0.999987587534406	0.688251075796334
down	CACNG7; NLGN1; NLGN2; SHANK1; SHANK3;	GO:2000311~regulation of AMPA receptor activity	5	21	23.8095238095238	0.00528775788064295	0.0797434563461577	1	1	0.999987587534406	0.999987587534406	0.705844832332767
down	GLI2; BMP5; NRG3; SIX1; ZIC1; TBX5;	GO:0007389~pattern specification process	6	31	19.3548387096774	0.00555140743332139	0.0827645191865139	1	1	0.999987587534406	0.999987587534406	0.732585604450311
down	CCL2; ADRB3; LHCGR; OPRM1; OPRD1; MC2R; HTR1B; HTR5A; CHRM2;	GO:0007187~G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger	9	65	13.8461538461538	0.00559901736540092	0.0831581329156704	1	1	0.999987587534406	0.999987587534406	0.736069654796139
up	P2RY10; GPR171; P2RY1; P2RY6; P2RY13; GPR87; P2RY12;	GO:0035589~G protein-coupled purinergic nucleotide receptor signaling pathway	7	14	50	0.00563599534256154	0.640893184668426	1	1	1	1	1
down	PBX3; NLGN1; NLGN2; PHOX2B;	GO:0002087~regulation of respiratory gaseous exchange by nervous system process	4	13	30.7692307692308	0.00589957155599341	0.0847334068536636	1	1	0.999987587534406	0.999987587534406	0.750013105702184
down	ISL1; TGFB2; SOX4; SEMA3C;	GO:0003215~cardiac right ventricle morphogenesis	4	13	30.7692307692308	0.00589957155599341	0.0847334068536636	1	1	0.999987587534406	0.999987587534406	0.750013105702184
down	FGF2; PDGFRB; FGFR1; PDGFRA;	GO:0010863~positive regulation of phospholipase C activity	4	13	30.7692307692308	0.00589957155599341	0.0847334068536636	1	1	0.999987587534406	0.999987587534406	0.750013105702184
down	FN1; APP; FBLN1; PCOLCE;	GO:0010952~positive regulation of peptidase activity	4	13	30.7692307692308	0.00589957155599341	0.0847334068536636	1	1	0.999987587534406	0.999987587534406	0.750013105702184
down	TYR; TYRP1; DCT; TRPC1;	GO:0042438~melanin biosynthetic process	4	13	30.7692307692308	0.00589957155599341	0.0847334068536636	1	1	0.999987587534406	0.999987587534406	0.750013105702184
down	FGF10; FOXF1; NFATC4; MYOCD;	GO:0051145~smooth muscle cell differentiation	4	13	30.7692307692308	0.00589957155599341	0.0847334068536636	1	1	0.999987587534406	0.999987587534406	0.750013105702184
down	ACTC1; SGCD; SGCG; SGCZ;	GO:0060047~heart contraction	4	13	30.7692307692308	0.00589957155599341	0.0847334068536636	1	1	0.999987587534406	0.999987587534406	0.750013105702184
down	INHBA; SOX11; TWIST1; OSR2;	GO:0061029~eyelid development in camera-type eye	4	13	30.7692307692308	0.00589957155599341	0.0847334068536636	1	1	0.999987587534406	0.999987587534406	0.750013105702184
down	COL3A1; COL5A1; MFAP4; LTBP2;	GO:0097435~supramolecular fiber organization	4	13	30.7692307692308	0.00589957155599341	0.0847334068536636	1	1	0.999987587534406	0.999987587534406	0.750013105702184
down	CLEC3B; HPN; MELTF;	GO:0010756~positive regulation of plasminogen activation	3	6	50	0.0060859110202518	0.0849211996811648	1	1	0.999987587534406	0.999987587534406	0.751675343620057
down	INHA; INHBA; FOXL2;	GO:0046881~positive regulation of follicle-stimulating hormone secretion	3	6	50	0.0060859110202518	0.0849211996811648	1	1	0.999987587534406	0.999987587534406	0.751675343620057
down	TCF21; LIF; FOXF1;	GO:0060426~lung vasculature development	3	6	50	0.0060859110202518	0.0849211996811648	1	1	0.999987587534406	0.999987587534406	0.751675343620057
down	SNAI2; MSX1; HAND2;	GO:0060536~cartilage morphogenesis	3	6	50	0.0060859110202518	0.0849211996811648	1	1	0.999987587534406	0.999987587534406	0.751675343620057
down	C1QL1; EN1; GPR88;	GO:0061743~motor learning	3	6	50	0.0060859110202518	0.0849211996811648	1	1	0.999987587534406	0.999987587534406	0.751675343620057
down	LIF; FAT4; WWTR1;	GO:0072307~regulation of metanephric nephron tubule epithelial cell differentiation	3	6	50	0.0060859110202518	0.0849211996811648	1	1	0.999987587534406	0.999987587534406	0.751675343620057
down	GREM1; SLIT2; NBL1;	GO:0090027~negative regulation of monocyte chemotaxis	3	6	50	0.0060859110202518	0.0849211996811648	1	1	0.999987587534406	0.999987587534406	0.751675343620057
down	CTNNA2; PFN2; WASF3;	GO:0098885~modification of postsynaptic actin cytoskeleton	3	6	50	0.0060859110202518	0.0849211996811648	1	1	0.999987587534406	0.999987587534406	0.751675343620057
down	TLL1; ELANE; MMP2; LAMC1; BMP1; TIMP2; MMP16; HTRA1; ADAMTS5;	GO:0022617~extracellular matrix disassembly	9	66	13.6363636363636	0.00611615073912397	0.0850405214471812	1	1	0.999987587534406	0.999987587534406	0.752731513690764
down	WNT7A; AGT; FGF1; ANGPT1; CCBE1; ADGRA2; ATOH8; FOXC2;	GO:0010595~positive regulation of endothelial cell migration	8	54	14.8148148148148	0.00615339374020063	0.085256031290907	1	1	0.999987587534406	0.999987587534406	0.75463908725831
down	SLIT2; BMP10; APOE; DCN; NR2F2;	GO:0010596~negative regulation of endothelial cell migration	5	22	22.7272727272727	0.00625458026794279	0.0863528494035341	1	1	0.999987587534406	0.999987587534406	0.764347512654949
down	ADAMTS2; MMP2; COL15A1; MRC2; MMP23B; MMP16; MMP17;	GO:0030574~collagen catabolic process	7	43	16.2790697674419	0.00648936813263834	0.0892800436774559	1	1	0.999987587534406	0.999987587534406	0.79025741230255
down	SOX12; TGFB1I1; SOX8; ROR2; NEUROD4; WNT3; WNT7A; WNT2;	GO:0045165~cell fate commitment	8	55	14.5454545454545	0.00677870881396603	0.0929346757327301	1	1	0.999987587534406	0.999987587534406	0.822606187593843
down	APOE; ADCY8; GRIA1; NFATC4; NPAS4; SHANK1;	GO:0007616~long-term memory	6	33	18.1818181818182	0.00722397272681274	0.0975461373356863	1	1	0.999987587534406	0.999987587534406	0.863424287173302
down	CCL8; CCL25; CCL2; CCL7; CCL11; CCL13;	GO:0048247~lymphocyte chemotaxis	6	33	18.1818181818182	0.00722397272681274	0.0975461373356863	1	1	0.999987587534406	0.999987587534406	0.863424287173302
down	HMX3; FOXS1; APP; IGDCC3; NLGN2; GPR88; SHANK1;	GO:0050885~neuromuscular process controlling balance	7	44	15.9090909090909	0.00723803546294044	0.0975461373356863	1	1	0.999987587534406	0.999987587534406	0.863424287173302
down	TGFB1I1; HTRA3; VASN; PEG10; FAM89B; WFIKKN2; HTRA1; PMEPA1; EMILIN1;	GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway	9	68	13.2352941176471	0.00725990013142985	0.0975461373356863	1	1	0.999987587534406	0.999987587534406	0.863424287173302
down	PDGFRB; LRP1; TBX2; SIX1;	GO:0035909~aorta morphogenesis	4	14	28.5714285714286	0.00732040179347848	0.0975461373356863	1	1	0.999987587534406	0.999987587534406	0.863424287173302
down	COL1A1; PDGFRB; CDKN1A; BNIP3;	GO:0055093~response to hyperoxia	4	14	28.5714285714286	0.00732040179347848	0.0975461373356863	1	1	0.999987587534406	0.999987587534406	0.863424287173302
down	KCNK2; CDKN1A; ANKRD1; RGN;	GO:2000279~negative regulation of DNA biosynthetic process	4	14	28.5714285714286	0.00732040179347848	0.0975461373356863	1	1	0.999987587534406	0.999987587534406	0.863424287173302
down	APOE; CRB1; SVEP1; MESP1; NOX4;	GO:0010467~gene expression	5	23	21.7391304347826	0.00733897233206515	0.0975461373356863	1	1	0.999987587534406	0.999987587534406	0.863424287173302
down	FOXS1; NUPR1; WFS1; PIM1; NR0B1; HAND2; TWIST1; SFRP4; GLIS2;	GO:0043433~negative regulation of DNA-binding transcription factor activity	9	69	13.0434782608696	0.00788967531442475	0.104511543607633	1	1	0.999987587534406	0.999987587534406	0.925078198947705
down	NUPR1; SOX11; SOX8; ANKRD1; SCX; PHOX2B; MYF6;	GO:0035914~skeletal muscle cell differentiation	7	45	15.5555555555556	0.00804872939202173	0.106000438972178	1	1	0.999987587534406	0.999987587534406	0.93825707464612
down	PENK; FGA; FGG; SLC6A1; TRPC1; KCNMA1; TRPC3; TPH2;	GO:0051592~response to calcium ion	8	57	14.0350877192982	0.00817193748801437	0.106000438972178	1	1	0.999987587534406	0.999987587534406	0.93825707464612
down	COL4A1; CHRNA1; COL4A5; LAMB2; PDZRN3; TMEFF1;	GO:0007528~neuromuscular junction development	6	34	17.6470588235294	0.00818423387126543	0.106000438972178	1	1	0.999987587534406	0.999987587534406	0.93825707464612
down	COL1A1; MSX1; HHEX; SIX1; SIX4; PYGO1;	GO:0034504~protein localization to nucleus	6	34	17.6470588235294	0.00818423387126543	0.106000438972178	1	1	0.999987587534406	0.999987587534406	0.93825707464612
down	TCF21; LIF; FOXF1; PKDCC; MYOCD; STK40;	GO:0048286~lung alveolus development	6	34	17.6470588235294	0.00818423387126543	0.106000438972178	1	1	0.999987587534406	0.999987587534406	0.93825707464612
down	SLIT3; SLIT2; SOX11; TGFB2; SOX4; ZFPM2;	GO:0060412~ventricular septum morphogenesis	6	34	17.6470588235294	0.00818423387126543	0.106000438972178	1	1	0.999987587534406	0.999987587534406	0.93825707464612
down	MGAT4D; MEI4; CLDN11; ADAMTS2; FSTL3; SERPINA5; ROS1; AR; AXL; HSPA2; NME5; SOX8; HILS1; CCIN; CCNI; SYCP1; RGN; TMEM119; NKAPL; MROH2B; DZIP1; CCDC155; DAZL; RPL10L; PAIP2; SOHLH2; RAI14; ADAM29; FAM9B; GGT5; NR0B1;	GO:0007283~spermatogenesis	31	407	7.61670761670762	0.00837021898453971	0.106000438972178	1	1	0.999987587534406	0.999987587534406	0.93825707464612
down	APP; TH; NHLH2;	GO:0007617~mating behavior	3	7	42.8571428571429	0.00840758391235585	0.106000438972178	1	1	0.999987587534406	0.999987587534406	0.93825707464612
down	ISL1; ISL2; HOXC10;	GO:0021520~spinal cord motor neuron cell fate specification	3	7	42.8571428571429	0.00840758391235585	0.106000438972178	1	1	0.999987587534406	0.999987587534406	0.93825707464612
down	WNT7A; MTPN; KNDC1;	GO:0021707~cerebellar granule cell differentiation	3	7	42.8571428571429	0.00840758391235585	0.106000438972178	1	1	0.999987587534406	0.999987587534406	0.93825707464612
down	NPR2; ANTXR1; KCNU1;	GO:0022414~reproductive process	3	7	42.8571428571429	0.00840758391235585	0.106000438972178	1	1	0.999987587534406	0.999987587534406	0.93825707464612
down	TGFB2; SIX1; SIX4;	GO:0048699~generation of neurons	3	7	42.8571428571429	0.00840758391235585	0.106000438972178	1	1	0.999987587534406	0.999987587534406	0.93825707464612
down	TCF21; NR0B1; SCX;	GO:0060008~Sertoli cell differentiation	3	7	42.8571428571429	0.00840758391235585	0.106000438972178	1	1	0.999987587534406	0.999987587534406	0.93825707464612
down	HPN; BMP5; VASN; DACT3; TBX5;	GO:0010719~negative regulation of epithelial to mesenchymal transition	5	24	20.8333333333333	0.00854772238228385	0.107421857246586	1	1	0.999987587534406	0.999987587534406	0.950838680580273
down	VIM; LAMB2; ROR1; ROR2;	GO:0014002~astrocyte development	4	15	26.6666666666667	0.00894940841270542	0.111398826622914	1	1	0.999987587534406	0.999987587534406	0.986040606998425
down	RBP4; FOXL2; TGFB2; MYOCD;	GO:0060065~uterus development	4	15	26.6666666666667	0.00894940841270542	0.111398826622914	1	1	0.999987587534406	0.999987587534406	0.986040606998425
down	CRLF1; FN1; COL1A2; MMP2; VIM; FGF2; PIM1; CCL2; LIF; IL11; CNTFR; OPRM1; CDKN1A; OPRD1; CCL11; IL13RA2; TWIST1; FSCN1; NDN; GREM2; IL1RAPL2; IL36A; NUMBL;	GO:0019221~cytokine-mediated signaling pathway	23	278	8.27338129496403	0.00908902894647734	0.1124229731834	1	1	0.999987587534406	0.999987587534406	0.995105784135117
down	MEIS2; RBP4; TGFB2; ABCB5; ADAMTS18; CHRDL1;	GO:0001654~eye development	6	35	17.1428571428571	0.00923278116441706	0.113841933791444	1	1	0.999987587534406	0.999987587534406	1
down	CDH11; NRG3; GRIK2; NLGN1; NLGN2; LRRC4C; NGF; GRIK4; GRIA1;	GO:0050804~modulation of chemical synaptic transmission	9	71	12.6760563380282	0.00927299908159651	0.113979402504514	1	1	0.999987587534406	0.999987587534406	1
up	ALOX12B; CLDN1; KRT16; FLG; FLG2; FA2H; ABCA12; HRNR; ALOXE3;	GO:0061436~establishment of skin barrier	9	25	36	0.0095988850441171	1	1	1	1	1	1
up	TYROBP; CTLA4; IL10; FCGR2B; MNDA; CD300A; TNFRSF13B;	GO:0030889~negative regulation of B cell proliferation	7	16	43.75	0.009760629123993	1	1	1	1	1	1
down	GPR37; PALM; HTR1B; ADCY8; OPRD1; OPRK1; NPY2R; GPR176;	GO:0007193~adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway	8	59	13.5593220338983	0.00976930500247697	0.119655747649891	1	1	0.999987587534406	0.999987587534406	1
down	CDH2; FAT4; AMIGO2; CADM3; NLGN1; SCARF2; CRB1;	GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules	7	47	14.8936170212766	0.00986775246069882	0.119655747649891	1	1	0.999987587534406	0.999987587534406	1
down	ABCC9; SLC4A3; CACNA2D1; CACNG7; KCNK15; KCND2; KCNIP3;	GO:0061337~cardiac conduction	7	47	14.8936170212766	0.00986775246069882	0.119655747649891	1	1	0.999987587534406	0.999987587534406	1
down	WNT3; SEMA6D; SEMA3E; SEMA3C; SEMA4A;	GO:0048843~negative regulation of axon extension involved in axon guidance	5	25	20	0.00988739154260765	0.119655747649891	1	1	0.999987587534406	0.999987587534406	1
down	BMP10; TPM1; COL11A1; ISL1; FOXC2;	GO:0055010~ventricular cardiac muscle tissue morphogenesis	5	25	20	0.00988739154260765	0.119655747649891	1	1	0.999987587534406	0.999987587534406	1
up	TRPM2; GATA1; FLT3; LILRB1; BATF3; TREM2;	GO:0097028~dendritic cell differentiation	6	12	50	0.0102525500778304	1	1	1	1	1	1
down	AR; GDNF; ISL1; DLX2; NEUROD4; FGFR1;	GO:0045597~positive regulation of cell differentiation	6	36	16.6666666666667	0.010373755249334	0.12173707796902	1	1	0.999987587534406	0.999987587534406	1
down	NUPR1; HPN; AR; GDF5; ISL1; TGFB2; RGN; WFDC1;	GO:0050680~negative regulation of epithelial cell proliferation	8	60	13.3333333333333	0.0106497916107811	0.12173707796902	1	1	0.999987587534406	0.999987587534406	1
down	TH; LGALS1; CYP7A1; ADCY8; GHRHR; SOX4; NOX4; FGF21;	GO:0071333~cellular response to glucose stimulus	8	60	13.3333333333333	0.0106497916107811	0.12173707796902	1	1	0.999987587534406	0.999987587534406	1
down	MT2A; MT1H; MT1L; MT1G;	GO:0010273~detoxification of copper ion	4	16	25	0.0107976364744036	0.12173707796902	1	1	0.999987587534406	0.999987587534406	1
down	WNT7A; AGT; INHBA; AGTR1;	GO:0032270~positive regulation of cellular protein metabolic process	4	16	25	0.0107976364744036	0.12173707796902	1	1	0.999987587534406	0.999987587534406	1
down	FGF2; CREB3L1; APLN; SPRY4;	GO:0040037~negative regulation of fibroblast growth factor receptor signaling pathway	4	16	25	0.0107976364744036	0.12173707796902	1	1	0.999987587534406	0.999987587534406	1
down	SYT7; SYT1; SYT3; RIMS4;	GO:0048791~calcium ion-regulated exocytosis of neurotransmitter	4	16	25	0.0107976364744036	0.12173707796902	1	1	0.999987587534406	0.999987587534406	1
down	ACTB; FRMPD4; ACTBL2; DBN1;	GO:0098974~postsynaptic actin cytoskeleton organization	4	16	25	0.0107976364744036	0.12173707796902	1	1	0.999987587534406	0.999987587534406	1
down	TERT; AGT; LRP1; ADAMTS1;	GO:1904754~positive regulation of vascular associated smooth muscle cell migration	4	16	25	0.0107976364744036	0.12173707796902	1	1	0.999987587534406	0.999987587534406	1
down	IGF1; HMGA2; HAND2; TWIST1;	GO:2000679~positive regulation of transcription regulatory region DNA binding	4	16	25	0.0107976364744036	0.12173707796902	1	1	0.999987587534406	0.999987587534406	1
down	DDR2; ROS1; ROR2; FGFR1; PDGFRB; ROR1; EPHA5; AXL; PDGFRA;	GO:0033674~positive regulation of kinase activity	9	73	12.3287671232877	0.010832047643121	0.12173707796902	1	1	0.999987587534406	0.999987587534406	1
up	CLDN5; CLDN1; CLDN8; CLDN17; CLDN18; CLDN2; CLDN10; CLDN16;	GO:0016338~calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules	8	21	38.0952380952381	0.01106281271953	1	1	1	1	1	1
up	CYP1A1; CYP2C9; CYP2C19; CYP4A11; CYP2E1; CYP2S1; CYP2F1; CYP2C18;	GO:0019373~epoxygenase P450 pathway	8	21	38.0952380952381	0.01106281271953	1	1	1	1	1	1
down	PENK; SOX11; SOX4;	GO:0014009~glial cell proliferation	3	8	37.5	0.0111803028266753	0.12173707796902	1	1	0.999987587534406	0.999987587534406	1
down	HOXB8; GDNF; PBX3;	GO:0021516~dorsal spinal cord development	3	8	37.5	0.0111803028266753	0.12173707796902	1	1	0.999987587534406	0.999987587534406	1
down	WFS1; ATP6V1B1; SHANK1;	GO:0042048~olfactory behavior	3	8	37.5	0.0111803028266753	0.12173707796902	1	1	0.999987587534406	0.999987587534406	1
down	ZFAND2B; IGFBP4; IGFBP3;	GO:0043567~regulation of insulin-like growth factor receptor signaling pathway	3	8	37.5	0.0111803028266753	0.12173707796902	1	1	0.999987587534406	0.999987587534406	1
down	CPS1; NOX4; CBSL;	GO:0050667~homocysteine metabolic process	3	8	37.5	0.0111803028266753	0.12173707796902	1	1	0.999987587534406	0.999987587534406	1
down	CDH2; SOX11; SOX4;	GO:0060563~neuroepithelial cell differentiation	3	8	37.5	0.0111803028266753	0.12173707796902	1	1	0.999987587534406	0.999987587534406	1
down	WNT2; MSX1; WNT3;	GO:0061180~mammary gland epithelium development	3	8	37.5	0.0111803028266753	0.12173707796902	1	1	0.999987587534406	0.999987587534406	1
down	FAP; PTGIS; DLC1;	GO:1900119~positive regulation of execution phase of apoptosis	3	8	37.5	0.0111803028266753	0.12173707796902	1	1	0.999987587534406	0.999987587534406	1
down	MEI4; SYCP1; CCDC155; ANKRD31; SPATA22;	GO:0007129~synapsis	5	26	19.2307692307692	0.0113642817563213	0.12173707796902	1	1	0.999987587534406	0.999987587534406	1
down	NCAN; DCN; BGN; CHST3; XYLT1;	GO:0030206~chondroitin sulfate biosynthetic process	5	26	19.2307692307692	0.0113642817563213	0.12173707796902	1	1	0.999987587534406	0.999987587534406	1
down	FZD7; APP; AR; MIF; APLN;	GO:0042327~positive regulation of phosphorylation	5	26	19.2307692307692	0.0113642817563213	0.12173707796902	1	1	0.999987587534406	0.999987587534406	1
down	PITX3; PENK; TACR3; RGS4; PPP1R1B;	GO:0043278~response to morphine	5	26	19.2307692307692	0.0113642817563213	0.12173707796902	1	1	0.999987587534406	0.999987587534406	1
down	SNAI2; TH; EN1; TYR; TYRP1;	GO:0043473~pigmentation	5	26	19.2307692307692	0.0113642817563213	0.12173707796902	1	1	0.999987587534406	0.999987587534406	1
down	CDH2; MYF6; CTNNA2; CDH15; CDON;	GO:0051149~positive regulation of muscle cell differentiation	5	26	19.2307692307692	0.0113642817563213	0.12173707796902	1	1	0.999987587534406	0.999987587534406	1
down	CCL25; PDGFRB; PDGFRA; AZU1; AGTR1; CXCL12; RHOG; CCR10; HMGB4;	GO:0060326~cell chemotaxis	9	74	12.1621621621622	0.0116814821729451	0.124464922826407	1	1	0.999987587534406	0.999987587534406	1
up	CD1A; CD1C; CD1E; CD1B;	GO:0048006~antigen processing and presentation, endogenous lipid antigen via MHC class Ib	4	5	80	0.0117479714083484	1	1	1	1	1	1
down	FGF10; FGF18; FGF1; FGF4; FGF2; PDGFRB; SBK2; FGFR1; FGF5; CCL2; SCG2; PDGFRA; FGF7; GDNF; GFRA1; ANGPT1; EPGN; SHC3; PSMF1; RIT2; SHANK3;	GO:0000165~MAPK cascade	21	254	8.26771653543307	0.0123327091770538	0.13104756824723	1	1	0.999987587534406	0.999987587534406	1
down	PLAU; CGA; SERPINE1; HMGB4;	GO:0010469~regulation of signaling receptor activity	4	17	23.5294117647059	0.0128751095660535	0.135044720311197	1	1	0.999987587534406	0.999987587534406	1
down	FZD7; COL1A1; LGALS1; SPOCK1;	GO:0010812~negative regulation of cell-substrate adhesion	4	17	23.5294117647059	0.0128751095660535	0.135044720311197	1	1	0.999987587534406	0.999987587534406	1
down	GABRR3; GABBR2; GABRA2; GABRA6; GABRA1;	GO:0007214~gamma-aminobutyric acid signaling pathway	5	27	18.5185185185185	0.0129844069261212	0.135044720311197	1	1	0.999987587534406	0.999987587534406	1
down	EDNRB; SOX8; ASIC2; NGF; GDNF;	GO:0007422~peripheral nervous system development	5	27	18.5185185185185	0.0129844069261212	0.135044720311197	1	1	0.999987587534406	0.999987587534406	1
down	UCHL1; GLRB; EFNB3; ZIC1; KLHL1;	GO:0007628~adult walking behavior	5	27	18.5185185185185	0.0129844069261212	0.135044720311197	1	1	0.999987587534406	0.999987587534406	1
down	FGF10; FGF7; ANK2; ANGPT1; FBLN5;	GO:0034394~protein localization to cell surface	5	27	18.5185185185185	0.0129844069261212	0.135044720311197	1	1	0.999987587534406	0.999987587534406	1
down	AGT; PDGFRB; AGTR1; CDKN1A; NOX4;	GO:2000379~positive regulation of reactive oxygen species metabolic process	5	27	18.5185185185185	0.0129844069261212	0.135044720311197	1	1	0.999987587534406	0.999987587534406	1
down	WNT7A; DGKI; CHRM2; HTR1B; PFN2; ADRA1A; RIMS4;	GO:2000300~regulation of synaptic vesicle exocytosis	7	50	14	0.0131330939994213	0.136229792517807	1	1	0.999987587534406	0.999987587534406	1
down	SDC3; GPC4; ADH1B; APOE; RBP4; LRP1; RARRES2; GPC6;	GO:0001523~retinoid metabolic process	8	63	12.6984126984127	0.013643450972032	0.141150319950759	1	1	0.999987587534406	0.999987587534406	1
up	APOA1; APOC3; APOA4; LPL; GPIHBP1;	GO:0034371~chylomicron remodeling	5	9	55.5555555555556	0.013805710999481	1	1	1	1	1	1
up	F13A1; IVL; FLG; SPRR1B; SPRR2E; SPRR1A; TGM3; TGM6; TGM7;	GO:0018149~peptide cross-linking	9	27	33.3333333333333	0.0140906279169396	1	1	1	1	1	1
down	TEAD2; MEGF8; MESP1;	GO:0003143~embryonic heart tube morphogenesis	3	9	33.3333333333333	0.0144181064349194	0.145330065119072	1	1	0.999987587534406	0.999987587534406	1
down	FOXF1; TBX5; RBM24;	GO:0003197~endocardial cushion development	3	9	33.3333333333333	0.0144181064349194	0.145330065119072	1	1	0.999987587534406	0.999987587534406	1
down	TRPC3; TRPC4; TRPC1;	GO:0006828~manganese ion transport	3	9	33.3333333333333	0.0144181064349194	0.145330065119072	1	1	0.999987587534406	0.999987587534406	1
down	AGT; APOE; AGTR1;	GO:0010873~positive regulation of cholesterol esterification	3	9	33.3333333333333	0.0144181064349194	0.145330065119072	1	1	0.999987587534406	0.999987587534406	1
down	GPS2; PTGIS; LMO3;	GO:0035360~positive regulation of peroxisome proliferator activated receptor signaling pathway	3	9	33.3333333333333	0.0144181064349194	0.145330065119072	1	1	0.999987587534406	0.999987587534406	1
down	FGFR1; TWIST1; SALL1;	GO:0042473~outer ear morphogenesis	3	9	33.3333333333333	0.0144181064349194	0.145330065119072	1	1	0.999987587534406	0.999987587534406	1
down	WNT7A; FZD7; TGFB2;	GO:0048103~somatic stem cell division	3	9	33.3333333333333	0.0144181064349194	0.145330065119072	1	1	0.999987587534406	0.999987587534406	1
down	WNT7A; FGF10; FZD7;	GO:0060054~positive regulation of epithelial cell proliferation involved in wound healing	3	9	33.3333333333333	0.0144181064349194	0.145330065119072	1	1	0.999987587534406	0.999987587534406	1
down	PXDN; LAMB2; LAMB1;	GO:0070831~basement membrane assembly	3	9	33.3333333333333	0.0144181064349194	0.145330065119072	1	1	0.999987587534406	0.999987587534406	1
down	FGA; FGG; RASL10B;	GO:0090277~positive regulation of peptide hormone secretion	3	9	33.3333333333333	0.0144181064349194	0.145330065119072	1	1	0.999987587534406	0.999987587534406	1
down	COL1A2; AGTR1; CDH13; RHOG; PDPN; CDC42EP5; GNA12; CDC42EP2; ARHGDIG;	GO:0007266~Rho protein signal transduction	9	77	11.6883116883117	0.01452858784091	0.146068186985149	1	1	0.999987587534406	0.999987587534406	1
down	FOXS1; GREM1; CRYAB; POU3F3; MYF6; NR2F2; NR0B1; HMGA2; FOXG1; SOX8; FOXL2; HHEX; FOXF2; TBX2; TWIST1; FOXD1; CRY2; NKAPL; BEND5; SCX; ESX1; TWIST2; ZFPM2; CREB3L1; ATOH8; MESP1; TCEAL7; GLIS2; SALL1; DKK3; SIX4; MAGEL2; LOXL2; SIX2; SIX5; SIX1; ZNF503;	GO:0045892~negative regulation of transcription, DNA-templated	37	530	6.9811320754717	0.0145714011993452	0.146123949111592	1	1	0.999987587534406	0.999987587534406	1
down	CHRNA1; CNGA3; MCOLN1; PIEZO2; HCN4;	GO:0006812~cation transport	5	28	17.8571428571429	0.0147534671730222	0.146823210115279	1	1	0.999987587534406	0.999987587534406	1
down	DGKI; AZU1; HTR1B; BDKRB1; LRP1;	GO:0007205~protein kinase C-activating G protein-coupled receptor signaling pathway	5	28	17.8571428571429	0.0147534671730222	0.146823210115279	1	1	0.999987587534406	0.999987587534406	1
down	PENK; COL3A1; OPRM1; CXCL12; CCL11;	GO:0009314~response to radiation	5	28	17.8571428571429	0.0147534671730222	0.146823210115279	1	1	0.999987587534406	0.999987587534406	1
down	ISL1; TGFB2; TBX2; TWIST1;	GO:0003203~endocardial cushion morphogenesis	4	18	22.2222222222222	0.0151908007950132	0.148536483584157	1	1	0.999987587534406	0.999987587534406	1
down	CGA; SCG5; PCSK2; PCSK1N;	GO:0016486~peptide hormone processing	4	18	22.2222222222222	0.0151908007950132	0.148536483584157	1	1	0.999987587534406	0.999987587534406	1
down	GLI2; EN2; BMP5; GBX2;	GO:0030902~hindbrain development	4	18	22.2222222222222	0.0151908007950132	0.148536483584157	1	1	0.999987587534406	0.999987587534406	1
down	ACTB; FLNC; FBLIM1; FERMT2;	GO:0034329~cell junction assembly	4	18	22.2222222222222	0.0151908007950132	0.148536483584157	1	1	0.999987587534406	0.999987587534406	1
down	MT2A; MT1G; MT1H; MT1L;	GO:0045926~negative regulation of growth	4	18	22.2222222222222	0.0151908007950132	0.148536483584157	1	1	0.999987587534406	0.999987587534406	1
down	BMP5; ISL1; SIX1; SIX4;	GO:0060037~pharyngeal system development	4	18	22.2222222222222	0.0151908007950132	0.148536483584157	1	1	0.999987587534406	0.999987587534406	1
down	WNT7A; ZNF365; SHANK3; SHANK1;	GO:0060997~dendritic spine morphogenesis	4	18	22.2222222222222	0.0151908007950132	0.148536483584157	1	1	0.999987587534406	0.999987587534406	1
down	WFS1; CHRNA1; GABRA1; GABRA6; GABRR3; GABRA2; GLRB;	GO:0050877~nervous system process	7	52	13.4615384615385	0.015700200913277	0.150753969672221	1	1	0.999987587534406	0.999987587534406	1
down	ACR; ADRB3; LHCGR; CAP2; ADCY8; GHRHR;	GO:0007190~activation of adenylate cyclase activity	6	40	15	0.0159414005816557	0.150753969672221	1	1	0.999987587534406	0.999987587534406	1
down	FGF10; TPM1; PFN2; HSPA2; GABARAPL2; RGN;	GO:0032781~positive regulation of ATPase activity	6	40	15	0.0159414005816557	0.150753969672221	1	1	0.999987587534406	0.999987587534406	1
down	BMP10; TPM1; ANKRD1; FHOD3; MYOZ1; SIX4;	GO:0045214~sarcomere organization	6	40	15	0.0159414005816557	0.150753969672221	1	1	0.999987587534406	0.999987587534406	1
down	DISP2; GLI2; EVC; NKX6-1; ROR2; FOXF1; CDON; DZIP1;	GO:0007224~smoothened signaling pathway	8	65	12.3076923076923	0.0159531809808239	0.150753969672221	1	1	0.999987587534406	0.999987587534406	1
down	SEMA3E; COL4A1; GBX2; NFATC4; FOXC2;	GO:0001569~branching involved in blood vessel morphogenesis	5	29	17.2413793103448	0.0166768261698913	0.150753969672221	1	1	0.999987587534406	0.999987587534406	1
down	FGF18; COL1A1; MMP16; TMEM119; SCX;	GO:0001958~endochondral ossification	5	29	17.2413793103448	0.0166768261698913	0.150753969672221	1	1	0.999987587534406	0.999987587534406	1
down	PITX3; FGFR1; EN2; MSX1; EN1;	GO:0030901~midbrain development	5	29	17.2413793103448	0.0166768261698913	0.150753969672221	1	1	0.999987587534406	0.999987587534406	1
down	SOX8; NKX6-1; BNIP3; GPR17; TRPC4;	GO:0048709~oligodendrocyte differentiation	5	29	17.2413793103448	0.0166768261698913	0.150753969672221	1	1	0.999987587534406	0.999987587534406	1
down	APP; MT1G; MT2A; MT1L; MT1H;	GO:0071280~cellular response to copper ion	5	29	17.2413793103448	0.0166768261698913	0.150753969672221	1	1	0.999987587534406	0.999987587534406	1
down	FXYD1; ABCC9; AGT; NPR2; TRPC1; DMPK; ATP2B3;	GO:1903779~regulation of cardiac conduction	7	53	13.2075471698113	0.0171088232881789	0.150753969672221	1	1	0.999987587534406	0.999987587534406	1
down	EML1; FSTL3; INHBA; BVES; MIXL1; PYGO1; PDGFRA; PDGFRB;	GO:0002244~hematopoietic progenitor cell differentiation	8	66	12.1212121212121	0.017208231115875	0.150753969672221	1	1	0.999987587534406	0.999987587534406	1
down	PITX3; CRYAB; WNT2; CDON; SIX5; CRYGN;	GO:0002088~lens development in camera-type eye	6	41	14.6341463414634	0.0176030905036316	0.150753969672221	1	1	0.999987587534406	0.999987587534406	1
down	ADCY8; TRPC1; ATP2B3; TRPC3; TRPC4; CALB2;	GO:0051480~regulation of cytosolic calcium ion concentration	6	41	14.6341463414634	0.0176030905036316	0.150753969672221	1	1	0.999987587534406	0.999987587534406	1
down	DDAH1; AGT; APOE; NPY2R;	GO:0007263~nitric oxide mediated signal transduction	4	19	21.0526315789474	0.0177526163888386	0.150753969672221	1	1	0.999987587534406	0.999987587534406	1
down	APOE; LRP1; GPS2; EEPD1;	GO:0010875~positive regulation of cholesterol efflux	4	19	21.0526315789474	0.0177526163888386	0.150753969672221	1	1	0.999987587534406	0.999987587534406	1
down	IGF1; PDGFRB; SEMA6D; NOX4;	GO:0014911~positive regulation of smooth muscle cell migration	4	19	21.0526315789474	0.0177526163888386	0.150753969672221	1	1	0.999987587534406	0.999987587534406	1
down	LBX1; ISL1; SOX4; MDGA2;	GO:0021522~spinal cord motor neuron differentiation	4	19	21.0526315789474	0.0177526163888386	0.150753969672221	1	1	0.999987587534406	0.999987587534406	1
down	MGP; COMP; TWIST1; DDR2;	GO:0030500~regulation of bone mineralization	4	19	21.0526315789474	0.0177526163888386	0.150753969672221	1	1	0.999987587534406	0.999987587534406	1
down	PDGFRA; BMP5; LHCGR; ROR2;	GO:0030539~male genitalia development	4	19	21.0526315789474	0.0177526163888386	0.150753969672221	1	1	0.999987587534406	0.999987587534406	1
down	SLIT2; PFN2; FHOD3; KANK4;	GO:0030837~negative regulation of actin filament polymerization	4	19	21.0526315789474	0.0177526163888386	0.150753969672221	1	1	0.999987587534406	0.999987587534406	1
down	AGT; APOE; EDNRB; CPS1;	GO:0042311~vasodilation	4	19	21.0526315789474	0.0177526163888386	0.150753969672221	1	1	0.999987587534406	0.999987587534406	1
down	TCF21; FOXF1; COL16A1;	GO:0001763~morphogenesis of a branching structure	3	10	30	0.0181302598069331	0.150753969672221	1	1	0.999987587534406	0.999987587534406	1
down	TAT; ALDH1L2; AADAT;	GO:0009058~biosynthetic process	3	10	30	0.0181302598069331	0.150753969672221	1	1	0.999987587534406	0.999987587534406	1
down	GDF5; TBX5; SALL3;	GO:0035136~forelimb morphogenesis	3	10	30	0.0181302598069331	0.150753969672221	1	1	0.999987587534406	0.999987587534406	1
down	IGFBP3; IGFBP4; NKX6-1;	GO:0044342~type B pancreatic cell proliferation	3	10	30	0.0181302598069331	0.150753969672221	1	1	0.999987587534406	0.999987587534406	1
down	WFS1; APP; MTPN;	GO:0051247~positive regulation of protein metabolic process	3	10	30	0.0181302598069331	0.150753969672221	1	1	0.999987587534406	0.999987587534406	1
down	DCN; ALOX12; MLLT11;	GO:0051901~positive regulation of mitochondrial depolarization	3	10	30	0.0181302598069331	0.150753969672221	1	1	0.999987587534406	0.999987587534406	1
down	HOXC11; OSR2; OSR1;	GO:0060272~embryonic skeletal joint morphogenesis	3	10	30	0.0181302598069331	0.150753969672221	1	1	0.999987587534406	0.999987587534406	1
down	QSOX1; COL1A2; HAPLN2;	GO:0085029~extracellular matrix assembly	3	10	30	0.0181302598069331	0.150753969672221	1	1	0.999987587534406	0.999987587534406	1
down	LRCOL1; ALPI; ADM2; UCN2; CYP39A1;	GO:0007586~digestion	5	30	16.6666666666667	0.0187594914838963	0.154205379682091	1	1	0.999987587534406	0.999987587534406	1
down	FGA; FGG; ADRA1A; ADRA1B; ADRA1D;	GO:0045907~positive regulation of vasoconstriction	5	30	16.6666666666667	0.0187594914838963	0.154205379682091	1	1	0.999987587534406	0.999987587534406	1
down	PALM; DPYSL3; FSCN1; PLPPR5; NLGN1;	GO:0051491~positive regulation of filopodium assembly	5	30	16.6666666666667	0.0187594914838963	0.154205379682091	1	1	0.999987587534406	0.999987587534406	1
down	SERPINE2; SYT1; CDH2; GRM1; DGKI;	GO:0051966~regulation of synaptic transmission, glutamatergic	5	30	16.6666666666667	0.0187594914838963	0.154205379682091	1	1	0.999987587534406	0.999987587534406	1
up	CYP1A1; CYP2C9; CYP2C19; CYP4A11; CYP4A22;	GO:0097267~omega-hydroxylase P450 pathway	5	10	50	0.018861431925965	1	1	1	1	1	1
down	RBP4; GIP; ISL1; NKX6-1; SOX4; NLGN2;	GO:0032024~positive regulation of insulin secretion	6	42	14.2857142857143	0.0193797452394336	0.158970671723471	1	1	0.999987587534406	0.999987587534406	1
down	TGFB1I1; TCF21; COL4A1; KRT3; DLX6; TAGLN; SIX1; BARX1;	GO:0030855~epithelial cell differentiation	8	68	11.7647058823529	0.0199283533058703	0.163129589378533	1	1	0.999987587534406	0.999987587534406	1
up	CXCL11; CXCL10; DRD1; IL13; APLNR; XCL1; CXCL9; NPSR1; F2RL3;	GO:0051281~positive regulation of release of sequestered calcium ion into cytosol	9	29	31.0344827586207	0.0199689642177857	1	1	1	1	1	1
down	FGF5; PDGFRA; MSX1; MESP1;	GO:0023019~signal transduction involved in regulation of gene expression	4	20	20	0.0205673903196226	0.166966330110228	1	1	0.999987587534406	0.999987587534406	1
down	PLAU; FGA; FGG; SERPINE1;	GO:0042730~fibrinolysis	4	20	20	0.0205673903196226	0.166966330110228	1	1	0.999987587534406	0.999987587534406	1
down	COL4A1; NR2F2; CDH2; LAMA1;	GO:0048514~blood vessel morphogenesis	4	20	20	0.0205673903196226	0.166966330110228	1	1	0.999987587534406	0.999987587534406	1
down	CDH2; CTNNA2; SHANK3; SHANK1;	GO:0048854~brain morphogenesis	4	20	20	0.0205673903196226	0.166966330110228	1	1	0.999987587534406	0.999987587534406	1
up	PGC; KLK7; KLK5;	GO:0002803~positive regulation of antibacterial peptide production	3	3	100	0.0206819736662146	1	1	1	1	1	1
up	TRPM2; P2RY1; P2RY6;	GO:0071415~cellular response to purine-containing compound	3	3	100	0.0206819736662146	1	1	1	1	1	1
up	LILRA5; LILRB1; TLR8;	GO:2001183~negative regulation of interleukin-12 secretion	3	3	100	0.0206819736662146	1	1	1	1	1	1
down	AGT; ANK2; BVES; HCN4; SCN10A;	GO:0002027~regulation of heart rate	5	31	16.1290322580645	0.0210060978418807	0.169824555954668	1	1	0.999987587534406	0.999987587534406	1
down	COL1A1; MMP2; PDGFRA; MSX1; SCX;	GO:0060325~face morphogenesis	5	31	16.1290322580645	0.0210060978418807	0.169824555954668	1	1	0.999987587534406	0.999987587534406	1
down	FOXS1; COL1A1; COL1A2; COL5A1; FOXF1; ANTXR1;	GO:0001568~blood vessel development	6	43	13.953488372093	0.0212746177027151	0.170588499002752	1	1	0.999987587534406	0.999987587534406	1
down	FGA; FGG; IGF1; VEGFC; TGFB2; ANKRD1;	GO:0050714~positive regulation of protein secretion	6	43	13.953488372093	0.0212746177027151	0.170588499002752	1	1	0.999987587534406	0.999987587534406	1
down	FGA; FGG; PDGFRA; MYL12A; COMP; ACTB;	GO:0070527~platelet aggregation	6	43	13.953488372093	0.0212746177027151	0.170588499002752	1	1	0.999987587534406	0.999987587534406	1
down	ABCC9; KCNJ8; KCNK9; HCN2; HCN4; SLC12A1;	GO:1990573~potassium ion import across plasma membrane	6	43	13.953488372093	0.0212746177027151	0.170588499002752	1	1	0.999987587534406	0.999987587534406	1
down	COL3A1; TH; CDH2; LRP1; BNIP3; NCOA1; CDON; FAT4;	GO:0021987~cerebral cortex development	8	69	11.5942028985507	0.0213971594711718	0.171220943441765	1	1	0.999987587534406	0.999987587534406	1
down	FGF10; OSR2; OSR1;	GO:0001823~mesonephros development	3	11	27.2727272727273	0.0223217689858364	0.175398108604137	1	1	0.999987587534406	0.999987587534406	1
down	NR0B1; OSR1; SALL1;	GO:0008406~gonad development	3	11	27.2727272727273	0.0223217689858364	0.175398108604137	1	1	0.999987587534406	0.999987587534406	1
down	TGFB1I1; VEGFC; TBX18;	GO:0016331~morphogenesis of embryonic epithelium	3	11	27.2727272727273	0.0223217689858364	0.175398108604137	1	1	0.999987587534406	0.999987587534406	1
down	PIM1; ITIH3; ITIH5;	GO:0030212~hyaluronan metabolic process	3	11	27.2727272727273	0.0223217689858364	0.175398108604137	1	1	0.999987587534406	0.999987587534406	1
down	PLAU; FGA; FGG;	GO:0031639~plasminogen activation	3	11	27.2727272727273	0.0223217689858364	0.175398108604137	1	1	0.999987587534406	0.999987587534406	1
down	AR; PDGFRA; NR0B1;	GO:0033327~Leydig cell differentiation	3	11	27.2727272727273	0.0223217689858364	0.175398108604137	1	1	0.999987587534406	0.999987587534406	1
down	FIGNL2; FIGN; TTLL6;	GO:0051013~microtubule severing	3	11	27.2727272727273	0.0223217689858364	0.175398108604137	1	1	0.999987587534406	0.999987587534406	1
down	GREM1; PMEPA1; EMILIN1;	GO:0060394~negative regulation of pathway-restricted SMAD protein phosphorylation	3	11	27.2727272727273	0.0223217689858364	0.175398108604137	1	1	0.999987587534406	0.999987587534406	1
down	FGFR1; FGF7; LAMA1;	GO:0060445~branching involved in salivary gland morphogenesis	3	11	27.2727272727273	0.0223217689858364	0.175398108604137	1	1	0.999987587534406	0.999987587534406	1
up	MUC6; MUC4; MUC13; TFF3; TFF2; TFF1;	GO:0030277~maintenance of gastrointestinal epithelium	6	15	40	0.0224793715549443	1	1	1	1	1	1
down	AR; COMP; EN1; PKDCC; STK40; SLITRK1; WWTR1; ETNK2; HEG1;	GO:0035264~multicellular organism growth	9	84	10.7142857142857	0.023114347577586	0.179992085183933	1	1	0.999987587534406	0.999987587534406	1
down	CCL2; CCL7; CCL25; CCL13; CCL11; CCL8;	GO:0002548~monocyte chemotaxis	6	44	13.6363636363636	0.0232907880985576	0.179992085183933	1	1	0.999987587534406	0.999987587534406	1
down	GREM1; VEGFC; HAND2; TWIST1; TWIST2; CHRD;	GO:0045668~negative regulation of osteoblast differentiation	6	44	13.6363636363636	0.0232907880985576	0.179992085183933	1	1	0.999987587534406	0.999987587534406	1
down	FGF10; TYR; HAND2; SIX1; SLC46A2; SIX4;	GO:0048538~thymus development	6	44	13.6363636363636	0.0232907880985576	0.179992085183933	1	1	0.999987587534406	0.999987587534406	1
down	SLC6A5; SLC6A3; SLC6A7; SLC6A1; AFP;	GO:0006810~transport	5	32	15.625	0.0234208932181286	0.179992085183933	1	1	0.999987587534406	0.999987587534406	1
down	WNT7A; HOXD11; FOXG1; EN1; SP8;	GO:0009953~dorsal/ventral pattern formation	5	32	15.625	0.0234208932181286	0.179992085183933	1	1	0.999987587534406	0.999987587534406	1
down	SOX12; PHGDH; SOX11; SOX4; ZIC1;	GO:0021510~spinal cord development	5	32	15.625	0.0234208932181286	0.179992085183933	1	1	0.999987587534406	0.999987587534406	1
down	AR; NR2F1; NR2F2; NR0B1; DCBLD2;	GO:0030522~intracellular receptor signaling pathway	5	32	15.625	0.0234208932181286	0.179992085183933	1	1	0.999987587534406	0.999987587534406	1
down	ADAMTS12; FAP; ADAMTS7; CTSF; CTSA;	GO:0051603~proteolysis involved in cellular protein catabolic process	5	32	15.625	0.0234208932181286	0.179992085183933	1	1	0.999987587534406	0.999987587534406	1
down	HSPB6; NUPR1; HAND2; MYOCD;	GO:0010667~negative regulation of cardiac muscle cell apoptotic process	4	21	19.047619047619	0.0236408885156147	0.179992085183933	1	1	0.999987587534406	0.999987587534406	1
down	SNAI2; SOX11; FOXC2; SOX8;	GO:0014032~neural crest cell development	4	21	19.047619047619	0.0236408885156147	0.179992085183933	1	1	0.999987587534406	0.999987587534406	1
down	EDNRB; USP13; TYRP1; SLC24A5;	GO:0030318~melanocyte differentiation	4	21	19.047619047619	0.0236408885156147	0.179992085183933	1	1	0.999987587534406	0.999987587534406	1
down	XIRP2; CLDN6; TGFB2; SDK2;	GO:0045216~cell-cell junction organization	4	21	19.047619047619	0.0236408885156147	0.179992085183933	1	1	0.999987587534406	0.999987587534406	1
down	MYOCD; TBX5; MESP1; NOX4;	GO:0055007~cardiac muscle cell differentiation	4	21	19.047619047619	0.0236408885156147	0.179992085183933	1	1	0.999987587534406	0.999987587534406	1
down	VEGFD; PITX3; EN1; PHOX2B;	GO:0071542~dopaminergic neuron differentiation	4	21	19.047619047619	0.0236408885156147	0.179992085183933	1	1	0.999987587534406	0.999987587534406	1
down	ADRA1A; ADRA1D; ADRA1B; ADRB3;	GO:0071880~adenylate cyclase-activating adrenergic receptor signaling pathway	4	21	19.047619047619	0.0236408885156147	0.179992085183933	1	1	0.999987587534406	0.999987587534406	1
up	UGT1A9; UGT1A1; CYP2C18; UGT1A3; CYP2S1; UGT1A7; UGT1A8; ADH1C;	GO:0042573~retinoic acid metabolic process	8	25	32	0.0240827006275713	1	1	1	1	1	1
up	S100A8; S100A9; SELE; CCR6; FUT7;	GO:0002523~leukocyte migration involved in inflammatory response	5	11	45.4545454545455	0.0249963155237575	1	1	1	1	1	1
up	CD1C; CD1A; CD1B; CD1E;	GO:0048007~antigen processing and presentation, exogenous lipid antigen via MHC class Ib	4	7	57.1428571428571	0.0256999379234928	1	1	1	1	1	1
down	FOXS1; IGF2; DIO3; SLC6A3; GHRHR;	GO:0040018~positive regulation of multicellular organism growth	5	33	15.1515151515152	0.0260077276319591	0.183119206669936	1	1	0.999987587534406	0.999987587534406	1
down	FBN1; COL16A1; ITGA11; ITGBL1;	GO:0033627~cell adhesion mediated by integrin	4	22	18.1818181818182	0.0269778213583596	0.183119206669936	1	1	0.999987587534406	0.999987587534406	1
down	ITGA3; ADRA1A; DLC1; HEG1;	GO:0035024~negative regulation of Rho protein signal transduction	4	22	18.1818181818182	0.0269778213583596	0.183119206669936	1	1	0.999987587534406	0.999987587534406	1
down	PITX3; TH; GAL; NR0B1;	GO:0035902~response to immobilization stress	4	22	18.1818181818182	0.0269778213583596	0.183119206669936	1	1	0.999987587534406	0.999987587534406	1
down	IGFBP3; CDON; RBM24; MYF6;	GO:0045663~positive regulation of myoblast differentiation	4	22	18.1818181818182	0.0269778213583596	0.183119206669936	1	1	0.999987587534406	0.999987587534406	1
down	WFS1; ATP6V1B1; SGCD; JPH2;	GO:0055074~calcium ion homeostasis	4	22	18.1818181818182	0.0269778213583596	0.183119206669936	1	1	0.999987587534406	0.999987587534406	1
down	CCBE1; PDPN; FOXC2;	GO:0001946~lymphangiogenesis	3	12	25	0.0269938539799089	0.183119206669936	1	1	0.999987587534406	0.999987587534406	1
down	DDAH1; AR; ADAMTS16;	GO:0003073~regulation of systemic arterial blood pressure	3	12	25	0.0269938539799089	0.183119206669936	1	1	0.999987587534406	0.999987587534406	1
down	CYP7A1; CYP39A1; APOE;	GO:0006707~cholesterol catabolic process	3	12	25	0.0269938539799089	0.183119206669936	1	1	0.999987587534406	0.999987587534406	1
down	RGN; RIT2; TMEM100;	GO:0050848~regulation of calcium-mediated signaling	3	12	25	0.0269938539799089	0.183119206669936	1	1	0.999987587534406	0.999987587534406	1
down	ADRA1A; CACNA2D1; JPH2;	GO:0060402~calcium ion transport into cytosol	3	12	25	0.0269938539799089	0.183119206669936	1	1	0.999987587534406	0.999987587534406	1
down	TERT; SOX11; HMGA2;	GO:2000648~positive regulation of stem cell proliferation	3	12	25	0.0269938539799089	0.183119206669936	1	1	0.999987587534406	0.999987587534406	1
down	COL3A1; NRG3; GPR173;	GO:2001223~negative regulation of neuron migration	3	12	25	0.0269938539799089	0.183119206669936	1	1	0.999987587534406	0.999987587534406	1
down	FGF10; LEFTY1; FOXF1; ARMC4; RIPPLY2; DNAH5; BICC1;	GO:0007368~determination of left/right symmetry	7	59	11.864406779661	0.0274660583258493	0.185680025337336	1	1	0.999987587534406	0.999987587534406	1
down	ZNF536; APP; LBX1; FOXG1; ISL1; ISL2; PHOX2B;	GO:0045665~negative regulation of neuron differentiation	7	59	11.864406779661	0.0274660583258493	0.185680025337336	1	1	0.999987587534406	0.999987587534406	1
down	ELN; SOX11; NPY2R; ISL1; TBX2; SIX1;	GO:0003151~outflow tract morphogenesis	6	46	13.0434782608696	0.0276984280372996	0.186287369355492	1	1	0.999987587534406	0.999987587534406	1
down	APP; MAP1S; KLHL1; LAMC2; MAP1B; TMEFF1;	GO:0016358~dendrite development	6	46	13.0434782608696	0.0276984280372996	0.186287369355492	1	1	0.999987587534406	0.999987587534406	1
down	DGKI; SLIT2; GPS2; RGN; GPSM1; WNK1;	GO:0034260~negative regulation of GTPase activity	6	46	13.0434782608696	0.0276984280372996	0.186287369355492	1	1	0.999987587534406	0.999987587534406	1
down	FGF2; WNT2; SCG2; CXCL12; CCL11; CDH13; VEGFC; VEGFD;	GO:0001938~positive regulation of endothelial cell proliferation	8	73	10.958904109589	0.0280385735797376	0.188252135284505	1	1	0.999987587534406	0.999987587534406	1
down	CDON; TBX18; TBX5; TBX4; TBX2;	GO:0001708~cell fate specification	5	34	14.7058823529412	0.0287700445298028	0.192504001026206	1	1	0.999987587534406	0.999987587534406	1
down	GJC1; FOXF1; TEAD2; MYOCD; ZFPM2; TMEM100; HEG1;	GO:0001570~vasculogenesis	7	60	11.6666666666667	0.0295306795468675	0.197256890124817	1	1	0.999987587534406	0.999987587534406	1
down	STC2; COL1A1; TH; GIP; CXCL12; HHEX;	GO:0043434~response to peptide hormone	6	47	12.7659574468085	0.0300951197473679	0.20034459173078	1	1	0.999987587534406	0.999987587534406	1
down	NOVA1; ACTN3; LAMA4; FOXC2; HOXC10; ADAMTS5;	GO:0120163~negative regulation of cold-induced thermogenesis	6	47	12.7659574468085	0.0300951197473679	0.20034459173078	1	1	0.999987587534406	0.999987587534406	1
down	ASPDH; DHRS7C; QSOX1; GPX5; FTH1; TH; SOD3; TYR; NQO1; TYRP1; CYP7A1; FMO3; DCT; ALDH5A1; DIO3; AOX1; CYP24A1; LOXL1; SELENBP1; PTGIS; ALDH1L2; P4HA3; P3H3; TPH2; ENOX1; GPX8; PXDN; HSD17B14; VKORC1; VAT1L; NOX4; SMOX; CYP39A1; CYP26A1; NOX3;	GO:0055114~oxidation-reduction process	35	526	6.65399239543726	0.0305182145271969	0.201193768370019	1	1	0.999987587534406	0.999987587534406	1
down	WNT2; FGFR1; FOXF1; CHRD;	GO:0002053~positive regulation of mesenchymal cell proliferation	4	23	17.3913043478261	0.030581863287052	0.201193768370019	1	1	0.999987587534406	0.999987587534406	1
down	APP; GRIA1; GRIK2; GRIK4;	GO:0035235~ionotropic glutamate receptor signaling pathway	4	23	17.3913043478261	0.030581863287052	0.201193768370019	1	1	0.999987587534406	0.999987587534406	1
down	TH; UCHL1; OPRM1; OPRD1;	GO:0042755~eating behavior	4	23	17.3913043478261	0.030581863287052	0.201193768370019	1	1	0.999987587534406	0.999987587534406	1
down	APOE; LRP1; CLIP3; CALY;	GO:0045807~positive regulation of endocytosis	4	23	17.3913043478261	0.030581863287052	0.201193768370019	1	1	0.999987587534406	0.999987587534406	1
down	APOE; NLGN1; SHANK3; SHANK1;	GO:0060999~positive regulation of dendritic spine development	4	23	17.3913043478261	0.030581863287052	0.201193768370019	1	1	0.999987587534406	0.999987587534406	1
down	SYT1; CACNG7; RNF157; SYT3;	GO:1903861~positive regulation of dendrite extension	4	23	17.3913043478261	0.030581863287052	0.201193768370019	1	1	0.999987587534406	0.999987587534406	1
down	WNT7A; KIF26B; ALPK2; FAM89B; FEZ1;	GO:0030010~establishment of cell polarity	5	35	14.2857142857143	0.0317108746237622	0.202633643213873	1	1	0.999987587534406	0.999987587534406	1
down	TERT; FGF2; TGFB2; ATOH8; APLN;	GO:1902895~positive regulation of pri-miRNA transcription by RNA polymerase II	5	35	14.2857142857143	0.0317108746237622	0.202633643213873	1	1	0.999987587534406	0.999987587534406	1
down	TERT; FGF10; SNAI2; GDNF; EYA4;	GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand	5	35	14.2857142857143	0.0317108746237622	0.202633643213873	1	1	0.999987587534406	0.999987587534406	1
down	PENK; GLRB; KCNA1;	GO:0001964~startle response	3	13	23.0769230769231	0.0321443830856998	0.202633643213873	1	1	0.999987587534406	0.999987587534406	1
down	APP; CNTFR; HAND2;	GO:0001967~suckling behavior	3	13	23.0769230769231	0.0321443830856998	0.202633643213873	1	1	0.999987587534406	0.999987587534406	1
down	SLIT3; TGFB2; TBX5;	GO:0003181~atrioventricular valve morphogenesis	3	13	23.0769230769231	0.0321443830856998	0.202633643213873	1	1	0.999987587534406	0.999987587534406	1
down	SNAI2; MSX1; TMEM100;	GO:0003198~epithelial to mesenchymal transition involved in endocardial cushion formation	3	13	23.0769230769231	0.0321443830856998	0.202633643213873	1	1	0.999987587534406	0.999987587534406	1
down	C8B; C7; CFHR5;	GO:0006957~complement activation, alternative pathway	3	13	23.0769230769231	0.0321443830856998	0.202633643213873	1	1	0.999987587534406	0.999987587534406	1
down	GREM1; NRG3; ANGPT1;	GO:0007171~activation of transmembrane receptor protein tyrosine kinase activity	3	13	23.0769230769231	0.0321443830856998	0.202633643213873	1	1	0.999987587534406	0.999987587534406	1
down	AGT; BNIP3; CAMK2A;	GO:0010666~positive regulation of cardiac muscle cell apoptotic process	3	13	23.0769230769231	0.0321443830856998	0.202633643213873	1	1	0.999987587534406	0.999987587534406	1
down	APOE; SERPINE1; SERPINE2;	GO:0030195~negative regulation of blood coagulation	3	13	23.0769230769231	0.0321443830856998	0.202633643213873	1	1	0.999987587534406	0.999987587534406	1
down	ADRA1A; NLGN1; NLGN2;	GO:0032230~positive regulation of synaptic transmission, GABAergic	3	13	23.0769230769231	0.0321443830856998	0.202633643213873	1	1	0.999987587534406	0.999987587534406	1
down	COL1A2; TNXB; P3H3;	GO:0032963~collagen metabolic process	3	13	23.0769230769231	0.0321443830856998	0.202633643213873	1	1	0.999987587534406	0.999987587534406	1
down	TBX4; PKDCC; MEGF8;	GO:0035108~limb morphogenesis	3	13	23.0769230769231	0.0321443830856998	0.202633643213873	1	1	0.999987587534406	0.999987587534406	1
down	PENK; APOE; NLGN2;	GO:0035641~locomotory exploration behavior	3	13	23.0769230769231	0.0321443830856998	0.202633643213873	1	1	0.999987587534406	0.999987587534406	1
down	DDAH1; SLIT2; ANGPT1;	GO:0043116~negative regulation of vascular permeability	3	13	23.0769230769231	0.0321443830856998	0.202633643213873	1	1	0.999987587534406	0.999987587534406	1
down	FGF10; FABP7; COL8A1;	GO:0050673~epithelial cell proliferation	3	13	23.0769230769231	0.0321443830856998	0.202633643213873	1	1	0.999987587534406	0.999987587534406	1
down	TRPA1; CXCL12; KCNA1;	GO:0050966~detection of mechanical stimulus involved in sensory perception of pain	3	13	23.0769230769231	0.0321443830856998	0.202633643213873	1	1	0.999987587534406	0.999987587534406	1
down	GABRA1; GABRA6; GABRA2;	GO:0051932~synaptic transmission, GABAergic	3	13	23.0769230769231	0.0321443830856998	0.202633643213873	1	1	0.999987587534406	0.999987587534406	1
down	BMP10; TGFB2; GDF6;	GO:0060389~pathway-restricted SMAD protein phosphorylation	3	13	23.0769230769231	0.0321443830856998	0.202633643213873	1	1	0.999987587534406	0.999987587534406	1
down	ISL1; TGFB2; TBX5;	GO:0060413~atrial septum morphogenesis	3	13	23.0769230769231	0.0321443830856998	0.202633643213873	1	1	0.999987587534406	0.999987587534406	1
down	TCF21; SOX11; STK40;	GO:0060425~lung morphogenesis	3	13	23.0769230769231	0.0321443830856998	0.202633643213873	1	1	0.999987587534406	0.999987587534406	1
down	FLRT2; COL4A1; NID2;	GO:0071711~basement membrane organization	3	13	23.0769230769231	0.0321443830856998	0.202633643213873	1	1	0.999987587534406	0.999987587534406	1
down	TERT; SERPINE1; CDKN1A;	GO:0090399~replicative senescence	3	13	23.0769230769231	0.0321443830856998	0.202633643213873	1	1	0.999987587534406	0.999987587534406	1
down	WNT7A; NLGN1; NLGN2;	GO:0099054~presynapse assembly	3	13	23.0769230769231	0.0321443830856998	0.202633643213873	1	1	0.999987587534406	0.999987587534406	1
down	HTR1B; ATP2B3; CALB2;	GO:0099509~regulation of presynaptic cytosolic calcium ion concentration	3	13	23.0769230769231	0.0321443830856998	0.202633643213873	1	1	0.999987587534406	0.999987587534406	1
up	SLC26A4; ANO1; SLC5A5;	GO:0015705~iodide transport	3	4	75	0.0332583531837396	1	1	1	1	1	1
up	CIDEA; APOA4; LY6D;	GO:0035634~response to stilbenoid	3	4	75	0.0332583531837396	1	1	1	1	1	1
down	TGFB2; CCL8; CCL13; CCL25; CCL11; PF4V1; CCL7; CCL2;	GO:0030593~neutrophil chemotaxis	8	76	10.5263157894737	0.0338695183292856	0.211529194630346	1	1	0.999987587534406	0.999987587534406	1
down	TNFRSF11B; WNT7A; F7; PDGFRB; GAL; GHRHR; TPH2;	GO:0043627~response to estrogen	7	62	11.2903225806452	0.0339677932408444	0.211529194630346	1	1	0.999987587534406	0.999987587534406	1
down	APOE; NPR2; EDNRB; NPPB;	GO:0019934~cGMP-mediated signaling	4	24	16.6666666666667	0.0344556784462827	0.211529194630346	1	1	0.999987587534406	0.999987587534406	1
down	ELN; DBN1; PFN2; ARHGAP28;	GO:0030833~regulation of actin filament polymerization	4	24	16.6666666666667	0.0344556784462827	0.211529194630346	1	1	0.999987587534406	0.999987587534406	1
down	STK40; WDR54; ROR2; ROR1;	GO:0043408~regulation of MAPK cascade	4	24	16.6666666666667	0.0344556784462827	0.211529194630346	1	1	0.999987587534406	0.999987587534406	1
down	HPN; GLI2; SIX1; CTHRC1;	GO:0090103~cochlea morphogenesis	4	24	16.6666666666667	0.0344556784462827	0.211529194630346	1	1	0.999987587534406	0.999987587534406	1
up	TRPM2; CXCR1; CCR2; CCR5; CCR6; CCL19;	GO:0002407~dendritic cell chemotaxis	6	17	35.2941176470588	0.0345727651947635	1	1	1	1	1	1
down	FN1; L1CAM; MAP1B; ISLR2; DBN1;	GO:0045773~positive regulation of axon extension	5	36	13.8888888888889	0.0348328320486293	0.211529194630346	1	1	0.999987587534406	0.999987587534406	1
up	SAA1; CCL26; XCL2; CCL23; CCL18; CCL24; CCL14; XCL1; CCL19;	GO:0048247~lymphocyte chemotaxis	9	33	27.2727272727273	0.0366741321772415	1	1	1	1	1	1
down	FGF10; AGT; IGF2; IGF1; MIF; LIF; IL11; FGF7; ANGPT1;	GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation	9	92	9.78260869565217	0.036774092560847	0.215855115166289	1	1	0.999987587534406	0.999987587534406	1
down	CCBE1; STK40; NDN;	GO:0003016~respiratory system process	3	14	21.4285714285714	0.0377682712706051	0.217778517135357	1	1	0.999987587534406	0.999987587534406	1
down	TAT; ALDH5A1; AADAT;	GO:0006536~glutamate metabolic process	3	14	21.4285714285714	0.0377682712706051	0.217778517135357	1	1	0.999987587534406	0.999987587534406	1
down	BMP10; ADRA1A; HAND2;	GO:0007512~adult heart development	3	14	21.4285714285714	0.0377682712706051	0.217778517135357	1	1	0.999987587534406	0.999987587534406	1
down	GIP; ASIC1; ASIC2;	GO:0010447~response to acidic pH	3	14	21.4285714285714	0.0377682712706051	0.217778517135357	1	1	0.999987587534406	0.999987587534406	1
down	NCAN; DCN; BGN;	GO:0030207~chondroitin sulfate catabolic process	3	14	21.4285714285714	0.0377682712706051	0.217778517135357	1	1	0.999987587534406	0.999987587534406	1
down	AGT; APOE; AGTR1;	GO:0034374~low-density lipoprotein particle remodeling	3	14	21.4285714285714	0.0377682712706051	0.217778517135357	1	1	0.999987587534406	0.999987587534406	1
down	GIP; ITGA3; LRRTM1;	GO:0035640~exploration behavior	3	14	21.4285714285714	0.0377682712706051	0.217778517135357	1	1	0.999987587534406	0.999987587534406	1
down	AGT; NPPB; EDNRB;	GO:0035815~positive regulation of renal sodium excretion	3	14	21.4285714285714	0.0377682712706051	0.217778517135357	1	1	0.999987587534406	0.999987587534406	1
down	CCL2; AZU1; EDNRB;	GO:0048246~macrophage chemotaxis	3	14	21.4285714285714	0.0377682712706051	0.217778517135357	1	1	0.999987587534406	0.999987587534406	1
down	BMP10; TGFB2; FOXC2;	GO:0060038~cardiac muscle cell proliferation	3	14	21.4285714285714	0.0377682712706051	0.217778517135357	1	1	0.999987587534406	0.999987587534406	1
down	WNT7A; TGFB2; LRRC32;	GO:0062009~secondary palate development	3	14	21.4285714285714	0.0377682712706051	0.217778517135357	1	1	0.999987587534406	0.999987587534406	1
down	MEIS2; OPRM1; LUM;	GO:0070848~response to growth factor	3	14	21.4285714285714	0.0377682712706051	0.217778517135357	1	1	0.999987587534406	0.999987587534406	1
down	SYT1; NLGN2; NLGN1; ACTBL2; ACTB;	GO:0048488~synaptic vesicle endocytosis	5	37	13.5135135135135	0.0381381126972448	0.219588164296471	1	1	0.999987587534406	0.999987587534406	1
down	GABBR2; EDNRB; GALR1; PALM;	GO:0007194~negative regulation of adenylate cyclase activity	4	25	16	0.0386009514165222	0.221278260971029	1	1	0.999987587534406	0.999987587534406	1
down	MIF; PRELP; TBX2; NOX4;	GO:0007569~cell aging	4	25	16	0.0386009514165222	0.221278260971029	1	1	0.999987587534406	0.999987587534406	1
down	MT2A; MT1G; MT1H; MT1L;	GO:0071294~cellular response to zinc ion	4	25	16	0.0386009514165222	0.221278260971029	1	1	0.999987587534406	0.999987587534406	1
up	WNT1; CYP1A1; HNF1B; HNF4A; PCK1;	GO:0070365~hepatocyte differentiation	5	13	38.4615384615385	0.0407455452922773	1	1	1	1	1	1
down	MIF; ISL1; NFATC4; TWIST1; SPON2; HMGB4;	GO:0032760~positive regulation of tumor necrosis factor production	6	51	11.7647058823529	0.0410191425960453	0.234454895217338	1	1	0.999987587534406	0.999987587534406	1
down	TH; EN1; NPAS4; SHANK3; GNG8; SHANK1;	GO:0035176~social behavior	6	51	11.7647058823529	0.0410191425960453	0.234454895217338	1	1	0.999987587534406	0.999987587534406	1
down	SDC3; GPC4; PDGFRB; XYLT1; GPC6;	GO:0006024~glycosaminoglycan biosynthetic process	5	38	13.1578947368421	0.0416284945932736	0.236901781277541	1	1	0.999987587534406	0.999987587534406	1
down	SHC3; GRIK4; GRIA1; SLC17A6; GRIK2;	GO:0035249~synaptic transmission, glutamatergic	5	38	13.1578947368421	0.0416284945932736	0.236901781277541	1	1	0.999987587534406	0.999987587534406	1
down	FGA; FGG; SERPINE1; BMP5; FAIM2;	GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors	5	38	13.1578947368421	0.0416284945932736	0.236901781277541	1	1	0.999987587534406	0.999987587534406	1
down	ASIC1; ASIC2; SLC24A5; NALCN; HCN2; HCN4; SCN10A; SLC12A1;	GO:0035725~sodium ion transmembrane transport	8	80	10	0.0428501046546701	0.237189488292009	1	1	0.999987587534406	0.999987587534406	1
down	APOE; NQO1; CHRNA1; SLC5A7;	GO:0007271~synaptic transmission, cholinergic	4	26	15.3846153846154	0.0430184221663334	0.237189488292009	1	1	0.999987587534406	0.999987587534406	1
down	AGT; SNAP25; ASIC1; SHANK1;	GO:0008306~associative learning	4	26	15.3846153846154	0.0430184221663334	0.237189488292009	1	1	0.999987587534406	0.999987587534406	1
down	CHST3; GAL3ST3; CHST8;	GO:0006790~sulfur compound metabolic process	3	15	20	0.0438578451660487	0.237189488292009	1	1	0.999987587534406	0.999987587534406	1
down	LIF; TGFB2; FOXC2;	GO:0033630~positive regulation of cell adhesion mediated by integrin	3	15	20	0.0438578451660487	0.237189488292009	1	1	0.999987587534406	0.999987587534406	1
down	WFS1; KANK2; AMIGO2;	GO:0043069~negative regulation of programmed cell death	3	15	20	0.0438578451660487	0.237189488292009	1	1	0.999987587534406	0.999987587534406	1
down	SNAI2; MIF; TWIST1;	GO:0043518~negative regulation of DNA damage response, signal transduction by p53 class mediator	3	15	20	0.0438578451660487	0.237189488292009	1	1	0.999987587534406	0.999987587534406	1
down	GIP; SCT; SCTR;	GO:0043950~positive regulation of cAMP-mediated signaling	3	15	20	0.0438578451660487	0.237189488292009	1	1	0.999987587534406	0.999987587534406	1
down	TH; FOXF2; TBX2;	GO:0048596~embryonic camera-type eye morphogenesis	3	15	20	0.0438578451660487	0.237189488292009	1	1	0.999987587534406	0.999987587534406	1
down	EDNRB; SIX1; SIX4;	GO:0050678~regulation of epithelial cell proliferation	3	15	20	0.0438578451660487	0.237189488292009	1	1	0.999987587534406	0.999987587534406	1
down	HTR1B; NPY2R; GRIK2;	GO:0051967~negative regulation of synaptic transmission, glutamatergic	3	15	20	0.0438578451660487	0.237189488292009	1	1	0.999987587534406	0.999987587534406	1
down	XIRP2; ACTC1; ANKRD1;	GO:0055008~cardiac muscle tissue morphogenesis	3	15	20	0.0438578451660487	0.237189488292009	1	1	0.999987587534406	0.999987587534406	1
down	KCNK2; RBP4; TBX5;	GO:0060044~negative regulation of cardiac muscle cell proliferation	3	15	20	0.0438578451660487	0.237189488292009	1	1	0.999987587534406	0.999987587534406	1
down	FABP7; CTNNA2; SLC6A3;	GO:0060134~prepulse inhibition	3	15	20	0.0438578451660487	0.237189488292009	1	1	0.999987587534406	0.999987587534406	1
down	BMP10; RBP4; ADAMTS1;	GO:0060347~heart trabecula formation	3	15	20	0.0438578451660487	0.237189488292009	1	1	0.999987587534406	0.999987587534406	1
down	AZU1; ANKRD1; FIBIN;	GO:0070528~protein kinase C signaling	3	15	20	0.0438578451660487	0.237189488292009	1	1	0.999987587534406	0.999987587534406	1
down	ACTN3; MYOZ1; HOMER3;	GO:0070885~negative regulation of calcineurin-NFAT signaling cascade	3	15	20	0.0438578451660487	0.237189488292009	1	1	0.999987587534406	0.999987587534406	1
down	SRPX2; SHANK3; SHANK1;	GO:0071625~vocalization behavior	3	15	20	0.0438578451660487	0.237189488292009	1	1	0.999987587534406	0.999987587534406	1
down	PAIP2; SHANK3; CALB2;	GO:1900271~regulation of long-term synaptic potentiation	3	15	20	0.0438578451660487	0.237189488292009	1	1	0.999987587534406	0.999987587534406	1
down	FGF2; FGFR1; APLN;	GO:1905564~positive regulation of vascular endothelial cell proliferation	3	15	20	0.0438578451660487	0.237189488292009	1	1	0.999987587534406	0.999987587534406	1
down	FGF2; PDGFRB; NOX4;	GO:2000573~positive regulation of DNA biosynthetic process	3	15	20	0.0438578451660487	0.237189488292009	1	1	0.999987587534406	0.999987587534406	1
down	COMP; SERPINH1; HSPB2; CHAC1; HSPB7; HSPA2;	GO:0006986~response to unfolded protein	6	52	11.5384615384615	0.0440933713192606	0.237189488292009	1	1	0.999987587534406	0.999987587534406	1
down	SERPINA3; CCL2; SCG2; MIF; AZU1; GAL; IGFBP4; AXL; BDKRB1; MAP2K3; NFATC4; TRIL; IL17D; RARRES2; NOX4; CCL11; IL36A; CCL8; PTGFR; PTGER1; PF4V1; CCL7; AGTR1; CCL13; GGT5; CCL25;	GO:0006954~inflammatory response	26	381	6.8241469816273	0.0441167414776508	0.237189488292009	1	1	0.999987587534406	0.999987587534406	1
down	RGS11; IGFBP3; RGS8; RGS22; DDIT4L;	GO:0009968~negative regulation of signal transduction	5	39	12.8205128205128	0.0453053401585641	0.237189488292009	1	1	0.999987587534406	0.999987587534406	1
up	HAAO; TDO2; IDO2; ACMSD;	GO:0006569~tryptophan catabolic process	4	9	44.4444444444444	0.0465912630981414	1	1	1	1	1	1
up	APOA4; LPL; CETP; APOA1;	GO:0034372~very-low-density lipoprotein particle remodeling	4	9	44.4444444444444	0.0465912630981414	1	1	1	1	1	1
up	IGHD; SAA1; ORM2; HMGB1P1;	GO:0050716~positive regulation of interleukin-1 secretion	4	9	44.4444444444444	0.0465912630981414	1	1	1	1	1	1
down	LIF; FBLN1; TIMP3; C1QL4; LMO3; SPRY4; EMILIN1;	GO:0070373~negative regulation of ERK1 and ERK2 cascade	7	67	10.4477611940298	0.0469299977136914	0.238667342458345	1	1	0.999987587534406	0.999987587534406	1
down	ACTB; CRB1; PARVA; CAP2; RHOG; FSCN1;	GO:0007163~establishment or maintenance of cell polarity	6	53	11.3207547169811	0.0473076924973355	0.239871686175638	1	1	0.999987587534406	0.999987587534406	1
down	IL33; ISL1; IL17D; SPON2; IL36A; HMGB4;	GO:0032755~positive regulation of interleukin-6 production	6	53	11.3207547169811	0.0473076924973355	0.239871686175638	1	1	0.999987587534406	0.999987587534406	1
down	RCVRN; TRPC3; ASIC2; GPR88;	GO:0007602~phototransduction	4	27	14.8148148148148	0.0477079244492986	0.240440580675707	1	1	0.999987587534406	0.999987587534406	1
down	GAL; HTR5A; EPHA5; GHRHR;	GO:0019933~cAMP-mediated signaling	4	27	14.8148148148148	0.0477079244492986	0.240440580675707	1	1	0.999987587534406	0.999987587534406	1
down	BDKRB1; VEGFC; ADM2; APLN;	GO:0045776~negative regulation of blood pressure	4	27	14.8148148148148	0.0477079244492986	0.240440580675707	1	1	0.999987587534406	0.999987587534406	1
down	THY1; ACTN3; FERMT2; DLC1;	GO:0048041~focal adhesion assembly	4	27	14.8148148148148	0.0477079244492986	0.240440580675707	1	1	0.999987587534406	0.999987587534406	1
up	CNR2; CD300LF; CD84;	GO:0033004~negative regulation of mast cell activation	3	5	60	0.0489258751811552	1	1	1	1	1	1
up	P2RY1; P2RX1; P2RY12;	GO:0043270~positive regulation of ion transport	3	5	60	0.0489258751811552	1	1	1	1	1	1
up	LTF; CLDN18; LILRB1;	GO:2001205~negative regulation of osteoclast development	3	5	60	0.0489258751811552	1	1	1	1	1	1
down	SNAI2; HMGA2; TGFB2; FOXF2; LOXL2;	GO:0001837~epithelial to mesenchymal transition	5	40	12.5	0.0491696002325346	0.246539645155714	1	1	0.999987587534406	0.999987587534406	1
down	TH; SCT; SCTR; TPH2; FGF21;	GO:0031667~response to nutrient levels	5	40	12.5	0.0491696002325346	0.246539645155714	1	1	0.999987587534406	0.999987587534406	1
down	PENK; NKX6-1; SLC6A3; PPP1R1B; CHRNA1;	GO:0035094~response to nicotine	5	40	12.5	0.0491696002325346	0.246539645155714	1	1	0.999987587534406	0.999987587534406	1
down	FXYD1; KCNA4; KCNA1; KCNMA1; KCNJ8; KCNF1; KCNK9;	GO:0006813~potassium ion transport	7	68	10.2941176470588	0.0498532532083952	0.247657715841693	1	1	0.999987587534406	0.999987587534406	1
down	PHGDH; COX7A1; AOX1; SH3BGRL3; NOX4; NDUFA4L2; LOXL2;	GO:0022900~electron transport chain	7	68	10.2941176470588	0.0498532532083952	0.247657715841693	1	1	0.999987587534406	0.999987587534406	1
